0001199835-22-000769.txt : 20221213 0001199835-22-000769.hdr.sgml : 20221213 20221213164240 ACCESSION NUMBER: 0001199835-22-000769 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 37 CONFORMED PERIOD OF REPORT: 20221031 FILED AS OF DATE: 20221213 DATE AS OF CHANGE: 20221213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Point of Care Nano-Technology, Inc. CENTRAL INDEX KEY: 0001504239 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 272830681 FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-56356 FILM NUMBER: 221460179 BUSINESS ADDRESS: STREET 1: 109 AMBERSWEET ROAD STREET 2: SUITE 401 CITY: DAVENPORT STATE: FL ZIP: 33897 BUSINESS PHONE: 732-723-7395 MAIL ADDRESS: STREET 1: 109 AMBERSWEET ROAD STREET 2: SUITE 401 CITY: DAVENPORT STATE: FL ZIP: 33897 FORMER COMPANY: FORMER CONFORMED NAME: Alternative Energy & Environmental Solutions, Inc. DATE OF NAME CHANGE: 20101025 10-Q 1 pcnt-10q.htm POINT OF CARE NANO-TECHNOLOGY, INC. 10-Q
0001504239 false --07-31 2023 Q1 P10Y 0001504239 2022-08-01 2022-10-31 0001504239 2022-12-13 0001504239 2022-10-31 0001504239 2022-07-31 0001504239 2021-08-01 2021-10-31 0001504239 us-gaap:PreferredStockMember 2022-07-31 0001504239 us-gaap:CommonStockMember 2022-07-31 0001504239 pcnt:ShareSubscriptionReceivedMember 2022-07-31 0001504239 us-gaap:TreasuryStockMember 2022-07-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2022-07-31 0001504239 us-gaap:RetainedEarningsMember 2022-07-31 0001504239 us-gaap:PreferredStockMember 2021-07-31 0001504239 us-gaap:CommonStockMember 2021-07-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2021-07-31 0001504239 us-gaap:RetainedEarningsMember 2021-07-31 0001504239 2021-07-31 0001504239 us-gaap:PreferredStockMember 2022-08-01 2022-10-31 0001504239 us-gaap:CommonStockMember 2022-08-01 2022-10-31 0001504239 pcnt:ShareSubscriptionReceivedMember 2022-08-01 2022-10-31 0001504239 us-gaap:TreasuryStockMember 2022-08-01 2022-10-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2022-08-01 2022-10-31 0001504239 us-gaap:RetainedEarningsMember 2022-08-01 2022-10-31 0001504239 us-gaap:PreferredStockMember 2021-08-01 2021-10-31 0001504239 us-gaap:CommonStockMember 2021-08-01 2021-10-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2021-08-01 2021-10-31 0001504239 us-gaap:RetainedEarningsMember 2021-08-01 2021-10-31 0001504239 us-gaap:PreferredStockMember 2022-10-31 0001504239 us-gaap:CommonStockMember 2022-10-31 0001504239 pcnt:ShareSubscriptionReceivedMember 2022-10-31 0001504239 us-gaap:TreasuryStockMember 2022-10-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001504239 us-gaap:RetainedEarningsMember 2022-10-31 0001504239 us-gaap:PreferredStockMember 2021-10-31 0001504239 us-gaap:CommonStockMember 2021-10-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2021-10-31 0001504239 us-gaap:RetainedEarningsMember 2021-10-31 0001504239 2021-10-31 0001504239 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember pcnt:NicholasDeVitoMember 2021-04-15 2021-04-15 0001504239 2022-06-08 2022-06-08 0001504239 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-08-02 0001504239 2022-04-15 0001504239 2021-08-01 2022-07-31 0001504239 2022-05-11 2022-05-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 10-Q
 

(Mark One)

 

  x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED: October 31, 2022

 

  o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from to

 

Commission File Number: 000-56356

 

POINT OF CARE NANO-TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)

 

Nevada   27-2830681
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification No.)
     
109 Ambersweet Way
Davenport, FL , 33897
(Address of principal executive offices) (Zip Code)
 
(732) 723-7395
(Registrant’s telephone number)
 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

 

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes x No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

o Large accelerated filer o Accelerated filer
x Non-accelerated Filer x Smaller reporting company
    o Emerging growth company
       

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Not applicable.        
         

The number of the registrant’s shares of common stock outstanding was 940,621 as of December 13, 2022.

1

 

Table of Contents

 

POINT OF CARE NANO-TECHNOLOGY, INC.

FORM 10-Q

 

TABLE OF CONTENTS

 

      Page
PART I—FINANCIAL INFORMATION    
     
Item 1. Financial Statements   3
  Condensed Balance Sheets as of October 31, 2022 (unaudited) and July 31, 2022   3
  Condensed Statements of Operations for the Three Months Ended October 31, 2022 (unaudited) and the Three Months Ended October 31, 2021 (unaudited)   4
  Condensed Statements of Changes in Stockholders’ Equity for the Three Months Ended October 31, 2022 (unaudited) and the Three Months Ended October 31, 2021 (unaudited)   5
  Condensed Statements of Cash Flows for the Three Months Ended October 31, 2022 (unaudited) and the Three Months Ended October 31, 2021 (unaudited)   6
  Notes to Condensed Financial Statements (unaudited)   7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   12
Item 3. Quantitative and Qualitative Disclosures About Market Risk   13
Item 4. Controls and Procedures   13
       
PART II—OTHER INFORMATION  
       
Item 1. Legal Proceedings   14
Item 1A. Risk Factors   14
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   15
Item 3. Defaults Upon Senior Securities   15
Item 4. Mine Safety Disclosures   15
Item 5. Other Information   15
Item 6. Exhibits   16
       
SIGNATURES 17

 

NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q for Point of Care Nano-Technology, Inc. may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are characterized by future or conditional verbs such as “may,” “will,” “expect,” “intend,” “anticipate,” believe,” “estimate” and “continue” or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. Such statements are only predictions and our actual results may differ materially from those anticipated in these forward-looking statements. We believe that it is important to communicate future expectations to investors. However, there may be events in the future that we are not able to accurately predict or control. Factors that may cause such differences include, but are not limited to, those discussed under Item 1A. Risk Factors in the Company’s 10K filed with the Securities and Exchange Commission (“SEC”) on October 25, 2022.

2

 

ITEM 1. FINANCIAL STATEMENTS

 

POINT OF CARE NANO-TECHNOLOGY, INC.

INTERIM BALANCE SHEETS

As of October 31, 2022 and July 31, 2022

(Unaudited)

 

   Oct 31,  2022   July 31, 2022 
ASSETS          
Current Assets          
Cash  $5,849    3,198 
Prepaid Expenses   1,167    2,917 
Current Assets   7,016    6,115 
Intangible Asset - License (Note 7)   122,316    123,466 
Total Assets  $129,332   $129,581 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current Liabilities          
Accounts Payable and Accrued Expenses  $231,156   $213,335 
Total Liabilities   231,156    213,335 
           
Stockholders’ Deficit          
Preferred Stock, par value $.0001; 10,000,000 shares authorized; 1,000 shares issued and outstanding (Note 5)   1    1 
Common Stock, par value $.0001; 100,000,000 shares authorized; 940,621 shares issued and outstanding (Note 5)   940    940 
Share subscriptions received   10,000    - 
Treasury Stock - 520,000 shares   (520)   (520)
Additional Paid-In Capital   120,191,707    120,191,707 
Accumulated Deficit   (120,303,952)   (120,275,882)
Total Stockholders’ Deficit   (101,824)   (83,754)
Total Liabilities and Stockholders’ Deficit  $129,332   $129,581 

 

See accompanying notes to the interim financial statements.

3

 

POINT OF CARE NANO-TECHNOLOGY, INC.

INTERIM STATEMENTS OF OPERATIONS

For the Three Months Ended October 31, 2022 and 2021

(Unaudited)

 

   For the Three Months
Ended
   For the Three Months
Ended
 
   Oct 31, 2022   Oct 31, 2021 
         
Operating Expenses          
Amortization Expense  $1,150   $- 
Consulting Expense   20,000    - 
General and Administrative Expense   3,722    - 
Professional Fees   3,198    42,254 
Officer compensation   -    1 
Operating expenses   28,070    42,255 
           
Net Loss and Comprehensive Loss  $(28,070)  $(42,255)
           
Net Loss per share, basic and diluted  $(0.03)  $(0.04)
           
Weighted average number of common shares outstanding   940,621    940,621 

 

See accompanying notes to the interim financial statements.

4

 

POINT OF CARE NANO-TECHNOLOGY, INC.

INTERIM STATEMENTS OF EQUITY

(Unaudited)

 

For the Three-Month Period Ended October 31, 2022

 

                   Share           Additional       Total 
                   Subscriptions           Paid-In   Accumulated   Stockholders 
   Preferred Stock   Common Stock   received   Treasury Stock   Capital   Deficit   Deficit 
                                     
   #   $   #   $       #   $   $   $   $ 
                                         
Balance, July 31, 2022   1,000   $1    940,621   $940   $-    (520,000)  $(520)  $120,191,707   $(120,275,882)  $(83,754)
Share subscriptions received   -    -    -    -    10,000    -    -    -    -    10,000 
Net Loss                                           (28,070)   (28,070)
Balance, Oct 31, 2022   1,000   $1    940,621   $940   $10,000    (520,000)  $(520)  $120,191,707   $(120,303,952)  $(101,824)

 

For the Three-Month Period Ended October 31, 2021

 

                   Additional       Total 
                   Paid-in   Accumulated   Stockholders’ 
   Preferred Stock   Common Stock   Capital   Deficit   Deficit 
   #   $   #   $   $   $   $ 
                             
Balance, July 31, 2021   -   $-    940,621   $940   $120,191,187   $(120,212,367   $(20,240)
Shares issued   1,000    1    -    -    -    -    1 
Net Loss                            (42,255)   (42,255)
Balance, Oct 31, 2021   1,000   $1    940,621   $940   $120,191,187  $(120,254,622)   $(62,494)

 

See accompanying notes to the interim financial statements.

5

 

POINT OF CARE NANO-TECHNOLOGY, INC.

INTERIM STATEMENTS OF CASH FLOWS

For the Three Months Ended October 31, 2022 and October 31, 2021

(Unaudited)

 

   For the Three Months Ended   For the Three Months Ended 
   Oct 31, 2022   Oct 31, 2021 
         
Cash Flows from Operating Activities:          
Net Loss  $(28,070)  $(42,255)
Non Cash Expense:          
Amortization   1,150    - 
Officer Compensation   -    1 
Change in Working Capital Items:          
Accounts payable and Accrued expenses   17,821    42,254 
Prepaid expense   1,750    -  
Net Cash Provided by Operating Activities   (7,349)   - 
           
Cash Flows from Financing Activities          
Share subscriptions received   10,000    - 
Net Cash Provided by Financing Activities   10,000    - 
Change in cash for the period   2,651    - 
Beginning Cash   3,198    - 
Ending Cash  $5,849   $- 

 

See accompanying notes to the interim financial statements.

6

 

POINT OF CARE NANO-TECHNOLOGY, INC.

INTERIM FINANCIAL STATEMENTS

For the Three Month Period Ended October 31, 2022

(Unaudited)

 

Note 1 COMPANY AND BACKGROUND

 

Point of Care Nano-Technology, Inc. (the “Company”) was incorporated under the laws of the State of Nevada on June 10, 2010, under the name of “Alternative Energy and Environmental Solutions, Inc.” On August 28, 2014, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to “Unique Growing Solutions, Inc.” On March 31, 2015, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to “Point of Care Nano-Technology, Inc.”

 

On February 26, 2015, the Company’s business model was related to using its license, under a certain license agreement (the “License Agreement”) from Lamina Equities Corporation, to first develop and then manufacture saliva-based medical diagnosis products. The Company was not successful and discontinued the majority of its operations by July 31, 2016. Beginning from August 2016, the Company’s plan, which it has since discontinued, was to provide business services and financing to emerging growth entities.

 

On April 15, 2021, the Company accepted the resignations of Dr. Guirguis and Mr. El-Salhy, received a mutual release from both, and appointed Mr. Nicholas DeVito to be Director, Chief Executive Officer and Chief Financial Officer. In addition, for his services to the Company, Mr. DeVito was awarded 1,000 shares of Class A Preferred Stock that grants him 80% voting rights.

 

Also on April 15, 2021 the Company agreed to form a subsidiary and transfer all debts and the License Agreement back to Dr. Guirguis in exchange for 520,000 shares of Common Stock. On August 231, 2021, the Company formed the wholly owned subsidiary, DRG Transfer, Inc. This transaction closed on March 26, 2022.

 

 On July 2, 2021, the Company incorporated a wholly owned subsidiary, Duo Sciences, Inc. (“DSI”).

 

On April 11, 2022, the Company, through DSI, acquired an exclusive license to distribute certain intellectual property in animal nutrition and animal supplements from Cedoga Consulting, LLC (“Cedoga”). On April 19, 2022, DSI signed an exclusive sales and promotion agreement with Lucy Pet Products Inc. (“Lucy”) pursuant to which Lucy will manufacture, market and distribute pet products from the Cedoga intellectual property.

 

The Company’s principal executive office location and mailing address is 109 Ambersweet Way, Davenport, FL 33897.

 

These financial statements have been prepared in accordance with generally accepted principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next twelve months. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classifications of assets and liabilities should the Company be unable to continue as a going concern. At October 31, 2022, the Company had not yet achieved profitable operations and had accumulated losses of $120,303,952 since its inception, all of which casts substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due.

 

Note 2 CONTROL BY PRINCIPAL OWNERS

 

The sole director and executive officer owns, directly, beneficially and in the aggregate, the majority of the voting power of the outstanding capital stock of the Company. Accordingly, the sole director and executive officer has the ability to control the approval of most corporate actions, including approving significant expenses, increasing the authorized capital and the dissolution, merger, or sale of the Company’s assets.

 

Note 3 INTERIM REPORTING

 

While the information presented in the accompanying interim three month financial statements is unaudited, it includes all adjustments, which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in accordance with accounting principles generally accepted in the United States of America. These interim financial statements follow the same accounting policies and methods of their application as the Company’s July 31, 2022 annual financial statements. All adjustments are of a normal recurring nature. It is suggested that these interim financial statements be read in conjunction with the Company’s July 31, 2022 annual financial statements. Operating results for the three months ended October 31, 2022 are not necessarily indicative of the results that can be expected for the year ended July 31, 2023.

7

 

Note 4 ACCOUNTING POLICIES

 

The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, the more significant of which are as follows:

 

Consolidation

 

The accompanying consolidated financial statement include the accounts of the Company and its wholly owned subsidiary Duo Sciences Inc. (“DSI”)

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Changes in estimates are recognized in accordance with the accounting rules for the estimate, which is typically in the period when new information becomes available to management. Actual results could differ from those estimates.

 

Financial Instruments

 

Financial instruments consist of cash and accounts payable and accrued liabilities. The carrying amounts of the financial instruments approximate their fair values due to their relatively short-term nature of the underlying terms are consistent with market terms. As of the financial statement date, the Company does not hold any derivate financial instruments. Financial assets and liabilities are measured upon first recognition and reviewed at the financial statement date. Changes in fair value are recognized through profit and loss. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest or credit risks arising from these financial instruments.

 

Fair Value Measurements

 

The Company follows FASB Codification topic (“ASC”) 820, Fair Value Measurements and Disclosures, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.

 

The Company has adopted FASB ASC 825, Financial Instruments, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Company has not elected the fair value option for any eligible financial instruments.

 

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities, and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

 

Income Taxes

 

The Company accounts for income taxes under FASB ASC Topic 740, Income Taxes (“ASC Topic 740”). Under ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As the Company has yet to produce positive cash flows from operations, no deferred tax asset or income taxes have been recorded in the financial statements.

8

 

Comprehensive Income (Loss)

 

The Company adopted FASB ASC 220, Reporting Comprehensive Income, which establishes standards for the reporting and display of comprehensive income and its components in the financial statements. Comprehensive income consists of net income and other gains and losses affecting stockholder’s equity that are excluded from net income, such as unrealized gains and losses on investments available for sale, foreign currency translation gains and losses and minimum pension liability. Since inception, the Company has not had any comprehensive income / loss.

 

Net Income (Loss) per Common Share

 

FASB ASC 260, Earnings per share, requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations. Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per share would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Diluted net income (loss) per share on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive. Accordingly, although the diluted weighted average number of common stock outstanding is disclosed on the statements of operation, the calculated net loss per share is the same for bother basic and diluted as both are based on the basic weighted average of common stock outstanding. There were no adjustments required to net income for the period presented in the computation of diluted earnings per share.

 

Segment Reporting

 

FASB ASC 820, “Segments Reporting,” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in financial statements. The Company currently operates in one principal business segment.

 

Intangible assets

 

Intangible asset are non-monetary identifiable assets, controlled by the Company that will produce future economic benefits, based on reasonable and supportable assumptions about conditions that will exist over the life of the asset. An intangible asset that does not meet these attributes will be recognized as an expense when it is incurred. Intangible assets that do, are capitalized and initially measure at cost. Those with a determinable life will be amortized on a systematic basis over their future economic life. Those with an indefinite useful life shall not be amortized until its useful life is determined to be longer than indefinite. An intangible asset subject to amortization shall be periodically reviewed for impairment. A recoverability test will be performed and, if applicable, unscheduled amortization is considered.

 

The license agreements has been capitalized, recorded at cost and amortized over its estimated useful life of ten years. Amortization has been determined based on a pro rata basis over the expected cash flows.

 

Non-cash transactions

 

The Company follows FASB ASC 845 then recording non-cash transactions. The value of the asset received should be based on the value of the assets surrendered. However, where that value is difficult to determine, then the value could be based on the asset received, provided it is more clearly evident than the value of the asset surrendered.

9

 

Related Parties

 

The Company adopted FASB ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

Recent Accounting Pronouncements

 

The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position, or cash flow.

 

The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, the more significant of which are as follows:

 

Recent Accounting Pronouncements

 

The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position, or cash flow.

 

Note 5 COMMON and PREFERRED STOCK

 

The Company has authorized capital of 100,000,000 shares of common stock, par value of $0.0001 per share, and 10,000,000 shares of “blank check” preferred stock, par value of $0.0001 per share, of which 1,000 shares have been designated as Series A Nonconvertible Preferred Stock (the “Series A Preferred Stock”).

 

The Company had the following transactions in its common stock during the three months ended October 31, 2022:

 

On August 24, 2022, the Company completed a financing with an investor for $10,000 in exchange for Units consisting of (i) one share of common stock, par value $0.001 per share for $0.10 per share, (ii) one LOI option to purchase one share of common stock for $0.20 per share upon the Company signing a letter of intent with a third party and (iii) one Agreement option to purchase one share of common stock for $0.30 per share upon the Company signing an agreement with a third party. The shares have not yet been issued and transactions has been recorded as subscriptions received.

 

During the year ended July 31, 2022, the Company had the following transactions in its common and preferred stock:

 

On June 8, 2022, the Company received approval from the Financial Industry Regulatory Authority to effect a 50:1 reverse split of the Company’s outstanding common stock. The split was reflected in the public markets on June 9, 2022 and has been given retroactive disclosure in the financial statements. Accordingly, all references to common shares in these financial statements reflect the reverse split.

 

On August 2, 2021, the Company issued 1,000 Series A Preferred Stock to Nicholas DeVito, the Company’s Chief Executive Officer as compensation. The Preferred Stock gives DeVito 80% control of the voting stock of the Company.

 

On April 10, 2022, the Company entered into an agreement under which it agreed to issue 300,000 common shares in order to obtain a license to distribute product (See below). The Company has not yet issued those shares and the obligation to do so is included in the accounts as a $125,000 liability.

 

On April 15, 2022, as part of the Settlement agreement (See below), the Company received into treasury 520,000 shares of common stock (26,000,000 pre reverse split shares).

10

 

There were no warrants or options outstanding as of October 31, 2022.

 

Note 6 SETTLEMENT AGREEMENT

 

On April 15, 2021, the Company formed a wholly owned subsidiary, DRG Transfer Inc. (“DRG”) and transferred all Company debts relating to the License Agreement business and the License Agreement to DRG to be split off to Dr. Guirguis in exchange for 520,000 share (26,000,000 shares pre reverse split) of the Company’s common stock held by Dr. Guirguis. This transaction closed on March 26, 2022 with Dr. Guirguis giving up and transferring to DRG all the rights, title and interest in the 520,000 shares and DRG contributing all of the legacy business debt and the License Agreement to DRG Transfer, Inc, a Nevada corporation, and transferring all of the outstanding capital stock in DRG Transfer, Inc. to Dr. Guirguis.

 

Note 7 LICENSE PURCHASED and INTANGIBLE ASSETS

 

On April 11, 2022, the Company, through its wholly owned subsidiary DSI, acquired an exclusive license to distribute in the USA, Canada and Mexico, certain intellectual property in animal nutrition and animal supplements from Cedoga Consulting, LLC. The Company receives 10% of all licensing fees due to Cedoga in exchange for 300,000 post reverse split shares of common stock of the Company. Under the terms of the agreement, the Company will pay royalties from sub-licensing on the following basis:

 

  90% of net royalties for sale and initial payments up to $100,000,000 per calendar year.

 

  95% of net royalties received for continuing sales above $100,000,000 per calendar year.

 

  90% of any lump up-front payment sub-licensing fees.

 

  Option to purchase 200,000 shares of the Company’s common stock when net sales exceed $100,000,000.

 

 The license value has been based on the expected discounted cash flows the license will generate to the Company over its estimated 10 year life. The Company’s common shares are very lightly traded and management determined that their market value are not reliable as a determinant of value for this transaction.

 

 

    October 31,     July 31,  
    2022     2022  
License   $ 125,000     $ 125,000  
Accumulated amortization     2,684       1,534  
Balance, end of year   $ 122,316     $ 123,466  

 

Note 8 EXCLUSIVE SALES  SUB-LICENSING AGREEMENT

 

On April 19, 2022, DSI signed an exclusive sales and promotion sub-licensing agreement with Lucy Pet Products Inc. (“Lucy”) pursuant to which Lucy will manufacture, market and distribute pet products derived from the Cedoga intellectual property. The terms of the sub-licensing agreement are as follows:

 

  Lucy will pay the Company a one-time sub-license fee of $100,000 on execution of the sub-licensing agreement.
     
  Lucy will pay the Company royalties of 5% of Net Revenue, calculated and payable quarterly. Net Revenue is defined as total revenue less direct cost of materials, manufacturing, packaging and delivery expenses and less excise, sales or similar taxes.

11

 

On May 11, 2022, the Company received the first payment from Lucy of $100,000 under its sub-license agreement with Lucy and remitted $90,000 to Cedoga according to the Cedoga license agreement.

 

Note 9 SUBSEQUENT EVENTS

 

On August 24, 2022, the Company completed a financing with an investor for $10,000 in exchange for Units consisting of (i) one share of common stock, par value $0.001 per share for $0.10 per share, (ii) one LOI option to purchase one share of common stock for $0.20 per share upon the Company signing a letter of intent with a third party and (iii) one Agreement option to purchase one share of common stock for $0.30 per share upon the Company signing an agreement with a third party.

 

On November 12, 2022 the investor exercised their right to purchase $10,000 of common stock for $0.20 per share.

 

On December 12, 2022, the Company entered into an asset purchase agreement with Global Foods Group, LLC (“GFG”) and its principal shareholder pursuant to which it agreed to acquire substantially all of the assets of GFG, consisting of assets relating to the sugar substitute that GFG has been developing, Jaca®. In exchange for the Jaca related assets, the Company will issue to GFG and its designees 7,000,000 shares of the Company’s common stock. Upon the closing of this transaction, which will effect a change of control of the Company, Peter Ferrari, the principal of the controlling member of GFG, will become the CEO and a director of the Company and Nicholas De Vito, the current CEO and controlling stockholder of the Company though the 1,000 shares of super-majority Class A Preferred Stock that he holds, will retain his positions with the Company as Treasurer, Secretary and Chief Financial Officer and director, and he will exchange his Class A Preferred shares for 2,000,000 shares of the common stock of the Company. The closing of this acquisition is contingent upon, among other things, GFG’s raising a minimum of $1,500,000 to be contributed to the Company upon closing as part of the purchased assets, for working capital purposes. There can be no assurances that GFG will be able to raise these funds or that this acquisition will successfully close.

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with our unaudited financial statements and the notes to those financial statements that are included elsewhere in this Form 10-Q. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. We use words such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” “predict,” and similar expressions to identify forward-looking statements. Any statement contained in this report that is not a statement of historical fact may be deemed to be a forward-looking statement. Although we believe that the plans, objectives, expectations and prospects reflected in or suggested by our forward-looking statements are reasonable, those statements involve risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by these forward-looking statements, and we can give no assurance that our plans, objectives, expectations and prospects will be achieved..

 

Overview

 

We were incorporated as Alternative Energy & Environmental Solutions, Inc. in the State of Nevada on June 10, 2010, and since that time we have attempted to develop certain technologies but have failed in these business endeavors. We changed our name in 2014 to Unique Growing Solutions, Inc. and again in 2015 to Point of Care Nano-Technology, Inc.

 

Our current plan of operation is to seek and acquire new business assets in the life sciences industry and begin operations with these new assets. To that end, on April 11, 2022, we, through our wholly owned subsidiary, Duo Sciences Inc. (“DSI”), acquired an exclusive license to distribute certain intellectual property in animal nutrition and animal supplements from Cedoga Consulting, LLC. On April 19, 2022, we, through DSI, signed an exclusive sales and promotion agreement with Lucy Pet Products Inc. (“Lucy”) pursuant to which Lucy will manufacture, market and distribute on our behalf pet products created from the Cedoga intellectual property.

12

 

On December 12, 2022, the Company entered into an asset purchase agreement with Global Foods Group, LLC (“GFG”) and its principal shareholder pursuant to which it agreed to acquire substantially all of the assets of GFG, consisting of assets relating to the sugar substitute that GFG has been developing, Jaca®. In exchange for the Jaca related assets, the Company will issue to GFG and its designees 7,000,000 shares of the Company’s common stock. Upon the closing of this transaction, which will effect a change of control of the Company, Peter Ferrari, the principal of the controlling member of GFG, will become the CEO and a director of the Company and Nicholas DeVito, the current CEO and controlling stockholder of the Company though the 1,000 shares of super-majority Class A Preferred Stock that he holds, will retain his positions with the Company as Treasurer, Secretary and Chief Financial Officer and director, and he will exchange his Class A Preferred shares for 2,000,000 shares of the common stock of the Company. The closing of this acquisition is contingent upon, among other things, GFG’s raising a minimum of $1,500,000 to be contributed to the Company upon closing as part of the purchased assets, for working capital purposes. There can be no assurances that GFG will be able to raise these funds or that this acquisition will successfully close.

 

RESULTS OF OPERATIONS

 

Comparison of Three Months Ended October 31, 2022 and 2021

 

Revenues

 

Our total revenue was $0 for the three-month periods ended October 31, 2022 and 2021, respectively. 

 

Cost of Goods Sold

 

Our cost of goods sold was $0 for the three-month periods ended October 31, 2022 and 2021, respectively. 

 

Operating Expenses (including Selling, General and Administrative Expenses)

 

For the three months ended October 31, 2022, our operating expenses increased to $ 28,071 from $ 42,255 for the three months ended October 31, 2021. The increase was primarily due to increased consulting, legal, filing and investor expenses.

 

Net Other Income (Expense)

 

Our net other income (expenses) was $0 for the three-month periods ended October 31, 2022 and 2021, respectively. 

 

Income Tax Expense

 

Income tax expense was $0 and $0 for the three-month period ended October 31, 2022 and 2021, respectively.

 

Net Loss

 

As a result of the foregoing factors, we had a net loss of $ (28,070) for the three months ended October 31, 2022, as compared to $(42,255) for the three months ended October 31, 2021.

 

LIQUIDITY AND CAPITAL RESOURCES

 

At October 31, 2022, we had $ 5,849 in cash, compared to $ -0- at October 31, 2021. At October 31, 2022, our accumulated deficit was $120,303,952 compared to $120,275,882 at July 31, 2022. There is substantial doubt as to our ability to continue as a going concern.

 

The Company has had no cash flow for the fiscal quarters ended October 31, 2022 and 2022 as well as none for the two years ended July 31, 2022 and 2021. In the future, the Company’s cash flow will depend on the timely and successful market entry of the Company’s expected strategic offerings, although we cannot guarantee that we will be successful in our strategic offering efforts.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Our principal executive and financial officer, Nicholas DeVito, evaluated the effectiveness of our disclosure controls and procedures as of October 31, 2022. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Securities Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Securities Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

13

 

Based on that evaluation, as of October 31, 2022, our interim principal executive and financial officer identified the following material weaknesses:

 

  We do not have sufficient and skilled accounting personnel with an appropriate level of technical accounting knowledge and experience in the application of accounting principles generally accepted in the United States commensurate with our financial reporting requirements. To mitigate the current limited resources and limited employees, we rely heavily on the use of external legal and accounting professionals.

 

Our management has identified the steps necessary to address the material weaknesses, and as soon as we have available funds, we will implement the following remedial procedures:

 

  We will hire personnel with technical accounting expertise to further support our current accounting personnel. As necessary, we will continue to engage consultants or outside accounting firms in order to ensure proper accounting for our financial statements.

 

We intend to complete the remediation of the material weaknesses discussed above as soon as practicable but we can give no assurance that we will be able to do so. Designing and implementing an effective disclosure controls and procedures is a continuous effort that requires us to anticipate and react to changes in our business and the economic and regulatory environments and to devote significant resources to maintain a financial reporting system that adequately satisfies our reporting obligations. The remedial measures that we have taken and intend to take may not fully address the material weaknesses that we have identified, and material weaknesses in our disclosure controls and procedures may be identified in the future. Should we discover such conditions, we intend to remediate them as soon as practicable. We are committed to taking appropriate steps for remediation, as needed.

 

Changes in Internal Control over Financial Reporting

 

As required by Rule 13a-15(d) of the Exchange Act, our management, including our interim principal executive and financial officer, Nicholas DeVito, conducted an evaluation of the internal control over financial reporting to determine whether any changes occurred during the quarter ended October 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Based on that evaluation, our acting principal executive and financial officer concluded there were no such changes during the quarter ended October 31, 2022.

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

From time to time, we may become involved in various lawsuits and legal proceedings, which arise, in the ordinary course of business. However, litigation is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition or operating results.

 

ITEM 1A. RISK FACTORS.

 

For a discussion of the risk factors affecting our business, see our annual report on Form 10-K, filed with the Securities and Exchange Commission on October 25, 2022.

14

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

 

During the three-month period ended October 31, 2022, we did not repurchase any of our common stock.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

None.

15

 

ITEM 6. EXHIBITS

 

The following exhibits are filed as part of this report or incorporated by reference:

 

Exhibit       Incorporated by Reference   Filed or
Furnished
Number   Exhibit Description   Form   Exhibit   Filing Date   Herewith
3.1   Articles of Incorporation.   S-1   3.1   10/25/2010    
3.2   Amendment to Articles of Incorporation, dated August 28, 2014.   8-K   3.1   10/30/2014    
3.3   Amendment to Articles of Incorporation, dated March 31, 2015.   8-K   3.1   04/08/2015    
3.4   Certificate of Amendment by Custodian dated July 1, 2020   10-12g     3.4   10/15/2021     
3.5   Certificate of Designation of the Series A Non-Convertible Preferred Stock    10-12g     3.5    10/15/2021    
3.6   Bylaws.   S-1   3.2   10/25/2010    
31.1/31.2   Certifications of Principal Executive Officer and Principal Financial and Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002               X
32.1/32.2   Certification of Principal Executive Officer and Principal Financial and Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002               X
101.INS   Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.               X
101.SCH   Inline XBRL Taxonomy Extension Schema Document               X
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document               X
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document               X
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document               X
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document               X
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)               X

16

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    POINT OF CARE NANO-TECHNOLOGY, INC.
    (Registrant)
Date: December 13, 2022    
  By: /s/ Nicholas DeVito
    Nicholas DeVito
    Chief Executive Officer
(Principal Executive and Financial and
Accounting Officer)

17

EX-31.1 2 pcnt-ex31.htm CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 

 

Exhibit 31.1, 31.2

 

CERTIFICATIONS

 

I, Nicholas DeVito, certify that:

 

  1. I have reviewed this quarterly report on Form 10-Q of Point of Care Nano-technology, Inc.;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: December 13, 2022

 

/s/ Nicholas DeVito
Nicholas DeVito
Chief Executive Officer
(Principal Executive and Financial and
Accounting Officer)

 

EX-32.1 3 pcnt-ex32.htm CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 

 

Exhibit 32.1, 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

 

The undersigned Interim Chief Executive Officer of Point of Care Nano-technology, Inc. (the “Company”), DOES HEREBY CERTIFY that:

 

1.       The Company’s Quarterly Report on Form 10-Q for the quarter ended October 31, 2022 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2.       Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

IN WITNESS WHEREOF, each of the undersigned has executed this statement this 13th day of December, 2022.

 

/s/ Nicholas DeVito
Nicholas DeVito
Chief Executive Officer
(Principal Executive and Financial and Accounting
Officer)

 

A signed original of this written statement required by Section 906 has been provided to Point of Care Nano-Technology, Inc. and will be retained by Point of Care Nano-Technology, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-101.SCH 4 pcnt-20221031.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - INTERIM BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - INTERIM BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - INTERIM STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - INTERIM STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - INTERIM STATEMENTS OF CASH FLOWS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - COMPANY AND BACKGROUND link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - CONTROL BY PRINCIPAL OWNERS link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - INTERIM REPORTING link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - COMMON and PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - SETTLEMENT AGREEMENT link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - EXCLUSIVE SALES SUB-LICENSING AGREEMENT link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - COMPANY AND BACKGROUND (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - COMMON and PREFERRED STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - EXCLUSIVE SALES SUB-LICENSING AGREEMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 pcnt-20221031_cal.xml XBRL CALCULATION FILE EX-101.DEF 6 pcnt-20221031_def.xml XBRL DEFINITION FILE EX-101.LAB 7 pcnt-20221031_lab.xml XBRL LABEL FILE Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Share Subscription Received [Member] Treasury Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Class of Stock [Axis] Series A Preferred Stock [Member] Related Party [Axis] Nicholas De Vito [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current Assets Cash Prepaid Expenses Current Assets Intangible Asset - License (Note 7) Total Assets LIABILITIES AND STOCKHOLDERS’ DEFICIT Current Liabilities Accounts Payable and Accrued Expenses Total Liabilities Stockholders’ Deficit Preferred Stock, par value $.0001; 10,000,000 shares authorized; 1,000 shares issued and outstanding (Note 5) Common Stock, par value $.0001; 100,000,000 shares authorized; 940,621 shares issued and outstanding (Note 5) Share subscriptions received Treasury Stock - 520,000 shares Additional Paid-In Capital Accumulated Deficit Total Stockholders’ Deficit Total Liabilities and Stockholders’ Deficit Preferred Stock, Par Value Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par Value Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Treasury Stock, Shares Income Statement [Abstract] Operating Expenses Amortization Expense Consulting Expense General and Administrative Expense Professional Fees Officer compensation Operating expenses Net Loss and Comprehensive Loss Net Loss per share, basic and diluted Weighted average number of common shares outstanding Statement [Table] Statement [Line Items] Beginning balance, value Beginning Balance, Shares Share subscriptions received Net Loss Shares issued Shares Issued, Shares Ending balance, value Ending Balance, Shares Statement of Cash Flows [Abstract] Cash Flows from Operating Activities: Non Cash Expense: Amortization Officer Compensation Change in Working Capital Items: Accounts payable and Accrued expenses Prepaid expense Net Cash Provided by Operating Activities Cash Flows from Financing Activities Net Cash Provided by Financing Activities Change in cash for the period Beginning Cash Ending Cash Accounting Policies [Abstract] COMPANY AND BACKGROUND Control By Principal Owners CONTROL BY PRINCIPAL OWNERS Quarterly Financial Information Disclosure [Abstract] INTERIM REPORTING ACCOUNTING POLICIES Equity [Abstract] COMMON and PREFERRED STOCK Settlement Agreement SETTLEMENT AGREEMENT License Purchased And Intangible Assets LICENSE PURCHASED and INTANGIBLE ASSETS Exclusive Sales Sub-licensing Agreement EXCLUSIVE SALES SUB-LICENSING AGREEMENT Subsequent Events [Abstract] SUBSEQUENT EVENTS Consolidation Use of Estimates Financial Instruments Fair Value Measurements Income Taxes Comprehensive Income (Loss) Net Income (Loss) per Common Share Segment Reporting Intangible assets Non-cash transactions Related Parties Recent Accounting Pronouncements Schedule of License Purchased LICENSE PURCHASED and INTANGIBLE ASSETS Stock Issued During Period, Value, New Issues Finite-Lived Intangible Asset, Useful Life Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Common Stock, Par or Stated Value Per Share Preferred Stock, Par or Stated Value Per Share Stockholders' Equity, Reverse Stock Split [custom:LicenseFeeToBePaidInCommonShares] License Accumulated amortization Balance, end of year Royalty Expense The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS). Assets, Current Assets Liabilities Treasury Stock, Value Stockholders' Equity Attributable to Parent Liabilities and Equity Operating Expenses [Default Label] Shares, Outstanding ShareSubscriptionReceived Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash and Cash Equivalents, at Carrying Value DisclosureLicensePurchasedAndIntangibleAssetsDetailsAbstract EX-101.PRE 8 pcnt-20221031_pre.xml XBRL PRESENTATION FILE XML 9 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover - shares
3 Months Ended
Oct. 31, 2022
Dec. 13, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Oct. 31, 2022  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --07-31  
Entity File Number 000-56356  
Entity Registrant Name POINT OF CARE NANO-TECHNOLOGY, INC.  
Entity Central Index Key 0001504239  
Entity Tax Identification Number 27-2830681  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 109 Ambersweet Way  
Entity Address, City or Town Davenport  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33897  
City Area Code (732)  
Local Phone Number 723-7395  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   940,621
XML 10 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTERIM BALANCE SHEETS (Unaudited) - USD ($)
Oct. 31, 2022
Jul. 31, 2022
Current Assets    
Cash $ 5,849 $ 3,198
Prepaid Expenses 1,167 2,917
Current Assets 7,016 6,115
Intangible Asset - License (Note 7) 122,316 123,466
Total Assets 129,332 129,581
Current Liabilities    
Accounts Payable and Accrued Expenses 231,156 213,335
Total Liabilities 231,156 213,335
Stockholders’ Deficit    
Preferred Stock, par value $.0001; 10,000,000 shares authorized; 1,000 shares issued and outstanding (Note 5) 1 1
Common Stock, par value $.0001; 100,000,000 shares authorized; 940,621 shares issued and outstanding (Note 5) 940 940
Share subscriptions received 10,000
Treasury Stock - 520,000 shares (520) (520)
Additional Paid-In Capital 120,191,707 120,191,707
Accumulated Deficit (120,303,952) (120,275,882)
Total Stockholders’ Deficit (101,824) (83,754)
Total Liabilities and Stockholders’ Deficit $ 129,332 $ 129,581
XML 11 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTERIM BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Oct. 31, 2022
Jul. 31, 2022
Statement of Financial Position [Abstract]    
Preferred Stock, Par Value $ 0.0001 $ 0.0001
Preferred Stock, Shares Authorized 10,000,000 10,000,000
Preferred Stock, Shares Issued 1,000 1,000
Preferred Stock, Shares Outstanding 1,000 1,000
Common Stock, Par Value $ 0.0001 $ 0.0001
Common Stock, Shares Authorized 100,000,000 100,000,000
Common Stock, Shares, Issued 940,621 940,621
Common Stock, Shares, Outstanding 940,621 940,621
Treasury Stock, Shares 520,000 520,000
XML 12 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTERIM STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Operating Expenses    
Amortization Expense $ 1,150
Consulting Expense 20,000
General and Administrative Expense 3,722
Professional Fees 3,198 42,254
Officer compensation 1
Operating expenses 28,070 42,255
Net Loss and Comprehensive Loss $ (28,070) $ (42,255)
Net Loss per share, basic and diluted $ (0.03) $ (0.04)
Weighted average number of common shares outstanding 940,621 940,621
XML 13 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTERIM STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Share Subscription Received [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Jul. 31, 2021 $ 940     $ 120,191,187 $ (120,212,367) $ (20,240)
Beginning Balance, Shares at Jul. 31, 2021 940,621          
Share subscriptions received            
Net Loss           (42,255) (42,255)
Shares issued $ 1     1
Shares Issued, Shares 1,000            
Ending balance, value at Oct. 31, 2021 $ 1 $ 940     120,191,187 (120,254,622) (62,494)
Ending Balance, Shares at Oct. 31, 2021 1,000 940,621          
Beginning balance, value at Jul. 31, 2022 $ 1 $ 940 $ (520) 120,191,707 (120,275,882) (83,754)
Beginning Balance, Shares at Jul. 31, 2022 1,000 940,621   (520,000)      
Share subscriptions received 10,000 10,000
Net Loss           (28,070) (28,070)
Ending balance, value at Oct. 31, 2022 $ 1 $ 940 $ 10,000 $ (520) $ 120,191,707 $ (120,303,952) $ (101,824)
Ending Balance, Shares at Oct. 31, 2022 1,000 940,621   (520,000)      
XML 14 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTERIM STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
3 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Cash Flows from Operating Activities:    
Net Loss $ (28,070) $ (42,255)
Non Cash Expense:    
Amortization 1,150
Officer Compensation 1
Change in Working Capital Items:    
Accounts payable and Accrued expenses 17,821 42,254
Prepaid expense 1,750
Net Cash Provided by Operating Activities (7,349)
Cash Flows from Financing Activities    
Share subscriptions received 10,000
Net Cash Provided by Financing Activities 10,000
Change in cash for the period 2,651
Beginning Cash 3,198
Ending Cash $ 5,849
XML 15 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMPANY AND BACKGROUND
3 Months Ended
Oct. 31, 2022
Accounting Policies [Abstract]  
COMPANY AND BACKGROUND

 

Note 1 COMPANY AND BACKGROUND

 

Point of Care Nano-Technology, Inc. (the “Company”) was incorporated under the laws of the State of Nevada on June 10, 2010, under the name of “Alternative Energy and Environmental Solutions, Inc.” On August 28, 2014, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to “Unique Growing Solutions, Inc.” On March 31, 2015, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to “Point of Care Nano-Technology, Inc.”

 

On February 26, 2015, the Company’s business model was related to using its license, under a certain license agreement (the “License Agreement”) from Lamina Equities Corporation, to first develop and then manufacture saliva-based medical diagnosis products. The Company was not successful and discontinued the majority of its operations by July 31, 2016. Beginning from August 2016, the Company’s plan, which it has since discontinued, was to provide business services and financing to emerging growth entities.

 

On April 15, 2021, the Company accepted the resignations of Dr. Guirguis and Mr. El-Salhy, received a mutual release from both, and appointed Mr. Nicholas DeVito to be Director, Chief Executive Officer and Chief Financial Officer. In addition, for his services to the Company, Mr. DeVito was awarded 1,000 shares of Class A Preferred Stock that grants him 80% voting rights.

 

Also on April 15, 2021 the Company agreed to form a subsidiary and transfer all debts and the License Agreement back to Dr. Guirguis in exchange for 520,000 shares of Common Stock. On August 231, 2021, the Company formed the wholly owned subsidiary, DRG Transfer, Inc. This transaction closed on March 26, 2022.

 

 On July 2, 2021, the Company incorporated a wholly owned subsidiary, Duo Sciences, Inc. (“DSI”).

 

On April 11, 2022, the Company, through DSI, acquired an exclusive license to distribute certain intellectual property in animal nutrition and animal supplements from Cedoga Consulting, LLC (“Cedoga”). On April 19, 2022, DSI signed an exclusive sales and promotion agreement with Lucy Pet Products Inc. (“Lucy”) pursuant to which Lucy will manufacture, market and distribute pet products from the Cedoga intellectual property.

 

The Company’s principal executive office location and mailing address is 109 Ambersweet Way, Davenport, FL 33897.

 

These financial statements have been prepared in accordance with generally accepted principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next twelve months. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classifications of assets and liabilities should the Company be unable to continue as a going concern. At October 31, 2022, the Company had not yet achieved profitable operations and had accumulated losses of $120,303,952 since its inception, all of which casts substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due.

XML 16 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONTROL BY PRINCIPAL OWNERS
3 Months Ended
Oct. 31, 2022
Control By Principal Owners  
CONTROL BY PRINCIPAL OWNERS

 

Note 2 CONTROL BY PRINCIPAL OWNERS

 

The sole director and executive officer owns, directly, beneficially and in the aggregate, the majority of the voting power of the outstanding capital stock of the Company. Accordingly, the sole director and executive officer has the ability to control the approval of most corporate actions, including approving significant expenses, increasing the authorized capital and the dissolution, merger, or sale of the Company’s assets.

XML 17 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTERIM REPORTING
3 Months Ended
Oct. 31, 2022
Quarterly Financial Information Disclosure [Abstract]  
INTERIM REPORTING

 

Note 3 INTERIM REPORTING

 

While the information presented in the accompanying interim three month financial statements is unaudited, it includes all adjustments, which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in accordance with accounting principles generally accepted in the United States of America. These interim financial statements follow the same accounting policies and methods of their application as the Company’s July 31, 2022 annual financial statements. All adjustments are of a normal recurring nature. It is suggested that these interim financial statements be read in conjunction with the Company’s July 31, 2022 annual financial statements. Operating results for the three months ended October 31, 2022 are not necessarily indicative of the results that can be expected for the year ended July 31, 2023.

XML 18 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCOUNTING POLICIES
3 Months Ended
Oct. 31, 2022
Accounting Policies [Abstract]  
ACCOUNTING POLICIES

Note 4 ACCOUNTING POLICIES

 

The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, the more significant of which are as follows:

 

Consolidation

 

The accompanying consolidated financial statement include the accounts of the Company and its wholly owned subsidiary Duo Sciences Inc. (“DSI”)

 

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Changes in estimates are recognized in accordance with the accounting rules for the estimate, which is typically in the period when new information becomes available to management. Actual results could differ from those estimates.

 

Financial Instruments

 

Financial instruments consist of cash and accounts payable and accrued liabilities. The carrying amounts of the financial instruments approximate their fair values due to their relatively short-term nature of the underlying terms are consistent with market terms. As of the financial statement date, the Company does not hold any derivate financial instruments. Financial assets and liabilities are measured upon first recognition and reviewed at the financial statement date. Changes in fair value are recognized through profit and loss. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest or credit risks arising from these financial instruments.

 

Fair Value Measurements

 

The Company follows FASB Codification topic (“ASC”) 820, Fair Value Measurements and Disclosures, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.

 

The Company has adopted FASB ASC 825, Financial Instruments, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Company has not elected the fair value option for any eligible financial instruments.

 

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities, and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

 

Income Taxes

 

The Company accounts for income taxes under FASB ASC Topic 740, Income Taxes (“ASC Topic 740”). Under ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As the Company has yet to produce positive cash flows from operations, no deferred tax asset or income taxes have been recorded in the financial statements.

Comprehensive Income (Loss)

 

The Company adopted FASB ASC 220, Reporting Comprehensive Income, which establishes standards for the reporting and display of comprehensive income and its components in the financial statements. Comprehensive income consists of net income and other gains and losses affecting stockholder’s equity that are excluded from net income, such as unrealized gains and losses on investments available for sale, foreign currency translation gains and losses and minimum pension liability. Since inception, the Company has not had any comprehensive income / loss.

 

Net Income (Loss) per Common Share

 

FASB ASC 260, Earnings per share, requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations. Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per share would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Diluted net income (loss) per share on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive. Accordingly, although the diluted weighted average number of common stock outstanding is disclosed on the statements of operation, the calculated net loss per share is the same for bother basic and diluted as both are based on the basic weighted average of common stock outstanding. There were no adjustments required to net income for the period presented in the computation of diluted earnings per share.

 

Segment Reporting

 

FASB ASC 820, “Segments Reporting,” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in financial statements. The Company currently operates in one principal business segment.

 

Intangible assets

 

Intangible asset are non-monetary identifiable assets, controlled by the Company that will produce future economic benefits, based on reasonable and supportable assumptions about conditions that will exist over the life of the asset. An intangible asset that does not meet these attributes will be recognized as an expense when it is incurred. Intangible assets that do, are capitalized and initially measure at cost. Those with a determinable life will be amortized on a systematic basis over their future economic life. Those with an indefinite useful life shall not be amortized until its useful life is determined to be longer than indefinite. An intangible asset subject to amortization shall be periodically reviewed for impairment. A recoverability test will be performed and, if applicable, unscheduled amortization is considered.

 

The license agreements has been capitalized, recorded at cost and amortized over its estimated useful life of ten years. Amortization has been determined based on a pro rata basis over the expected cash flows.

 

Non-cash transactions

 

The Company follows FASB ASC 845 then recording non-cash transactions. The value of the asset received should be based on the value of the assets surrendered. However, where that value is difficult to determine, then the value could be based on the asset received, provided it is more clearly evident than the value of the asset surrendered.

Related Parties

 

The Company adopted FASB ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

Recent Accounting Pronouncements

 

The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position, or cash flow.

 

The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, the more significant of which are as follows:

 

Recent Accounting Pronouncements

 

The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position, or cash flow.

XML 19 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMON and PREFERRED STOCK
3 Months Ended
Oct. 31, 2022
Equity [Abstract]  
COMMON and PREFERRED STOCK

 

Note 5 COMMON and PREFERRED STOCK

 

The Company has authorized capital of 100,000,000 shares of common stock, par value of $0.0001 per share, and 10,000,000 shares of “blank check” preferred stock, par value of $0.0001 per share, of which 1,000 shares have been designated as Series A Nonconvertible Preferred Stock (the “Series A Preferred Stock”).

 

The Company had the following transactions in its common stock during the three months ended October 31, 2022:

 

On August 24, 2022, the Company completed a financing with an investor for $10,000 in exchange for Units consisting of (i) one share of common stock, par value $0.001 per share for $0.10 per share, (ii) one LOI option to purchase one share of common stock for $0.20 per share upon the Company signing a letter of intent with a third party and (iii) one Agreement option to purchase one share of common stock for $0.30 per share upon the Company signing an agreement with a third party. The shares have not yet been issued and transactions has been recorded as subscriptions received.

 

During the year ended July 31, 2022, the Company had the following transactions in its common and preferred stock:

 

On June 8, 2022, the Company received approval from the Financial Industry Regulatory Authority to effect a 50:1 reverse split of the Company’s outstanding common stock. The split was reflected in the public markets on June 9, 2022 and has been given retroactive disclosure in the financial statements. Accordingly, all references to common shares in these financial statements reflect the reverse split.

 

On August 2, 2021, the Company issued 1,000 Series A Preferred Stock to Nicholas DeVito, the Company’s Chief Executive Officer as compensation. The Preferred Stock gives DeVito 80% control of the voting stock of the Company.

 

On April 10, 2022, the Company entered into an agreement under which it agreed to issue 300,000 common shares in order to obtain a license to distribute product (See below). The Company has not yet issued those shares and the obligation to do so is included in the accounts as a $125,000 liability.

 

On April 15, 2022, as part of the Settlement agreement (See below), the Company received into treasury 520,000 shares of common stock (26,000,000 pre reverse split shares).

There were no warrants or options outstanding as of October 31, 2022.

XML 20 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
SETTLEMENT AGREEMENT
3 Months Ended
Oct. 31, 2022
Settlement Agreement  
SETTLEMENT AGREEMENT

 

Note 6 SETTLEMENT AGREEMENT

 

On April 15, 2021, the Company formed a wholly owned subsidiary, DRG Transfer Inc. (“DRG”) and transferred all Company debts relating to the License Agreement business and the License Agreement to DRG to be split off to Dr. Guirguis in exchange for 520,000 share (26,000,000 shares pre reverse split) of the Company’s common stock held by Dr. Guirguis. This transaction closed on March 26, 2022 with Dr. Guirguis giving up and transferring to DRG all the rights, title and interest in the 520,000 shares and DRG contributing all of the legacy business debt and the License Agreement to DRG Transfer, Inc, a Nevada corporation, and transferring all of the outstanding capital stock in DRG Transfer, Inc. to Dr. Guirguis.

XML 21 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
LICENSE PURCHASED and INTANGIBLE ASSETS
3 Months Ended
Oct. 31, 2022
License Purchased And Intangible Assets  
LICENSE PURCHASED and INTANGIBLE ASSETS

 

Note 7 LICENSE PURCHASED and INTANGIBLE ASSETS

 

On April 11, 2022, the Company, through its wholly owned subsidiary DSI, acquired an exclusive license to distribute in the USA, Canada and Mexico, certain intellectual property in animal nutrition and animal supplements from Cedoga Consulting, LLC. The Company receives 10% of all licensing fees due to Cedoga in exchange for 300,000 post reverse split shares of common stock of the Company. Under the terms of the agreement, the Company will pay royalties from sub-licensing on the following basis:

 

  90% of net royalties for sale and initial payments up to $100,000,000 per calendar year.

 

  95% of net royalties received for continuing sales above $100,000,000 per calendar year.

 

  90% of any lump up-front payment sub-licensing fees.

 

  Option to purchase 200,000 shares of the Company’s common stock when net sales exceed $100,000,000.

 

 The license value has been based on the expected discounted cash flows the license will generate to the Company over its estimated 10 year life. The Company’s common shares are very lightly traded and management determined that their market value are not reliable as a determinant of value for this transaction.

 

 

    October 31,     July 31,  
    2022     2022  
License   $ 125,000     $ 125,000  
Accumulated amortization     2,684       1,534  
Balance, end of year   $ 122,316     $ 123,466  

XML 22 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
EXCLUSIVE SALES SUB-LICENSING AGREEMENT
3 Months Ended
Oct. 31, 2022
Exclusive Sales Sub-licensing Agreement  
EXCLUSIVE SALES SUB-LICENSING AGREEMENT

 

Note 8 EXCLUSIVE SALES  SUB-LICENSING AGREEMENT

 

On April 19, 2022, DSI signed an exclusive sales and promotion sub-licensing agreement with Lucy Pet Products Inc. (“Lucy”) pursuant to which Lucy will manufacture, market and distribute pet products derived from the Cedoga intellectual property. The terms of the sub-licensing agreement are as follows:

 

  Lucy will pay the Company a one-time sub-license fee of $100,000 on execution of the sub-licensing agreement.
     
  Lucy will pay the Company royalties of 5% of Net Revenue, calculated and payable quarterly. Net Revenue is defined as total revenue less direct cost of materials, manufacturing, packaging and delivery expenses and less excise, sales or similar taxes.

On May 11, 2022, the Company received the first payment from Lucy of $100,000 under its sub-license agreement with Lucy and remitted $90,000 to Cedoga according to the Cedoga license agreement.

XML 23 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUBSEQUENT EVENTS
3 Months Ended
Oct. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

 

Note 9 SUBSEQUENT EVENTS

 

On August 24, 2022, the Company completed a financing with an investor for $10,000 in exchange for Units consisting of (i) one share of common stock, par value $0.001 per share for $0.10 per share, (ii) one LOI option to purchase one share of common stock for $0.20 per share upon the Company signing a letter of intent with a third party and (iii) one Agreement option to purchase one share of common stock for $0.30 per share upon the Company signing an agreement with a third party.

 

On November 12, 2022 the investor exercised their right to purchase $10,000 of common stock for $0.20 per share.

 

On December 12, 2022, the Company entered into an asset purchase agreement with Global Foods Group, LLC (“GFG”) and its principal shareholder pursuant to which it agreed to acquire substantially all of the assets of GFG, consisting of assets relating to the sugar substitute that GFG has been developing, Jaca®. In exchange for the Jaca related assets, the Company will issue to GFG and its designees 7,000,000 shares of the Company’s common stock. Upon the closing of this transaction, which will effect a change of control of the Company, Peter Ferrari, the principal of the controlling member of GFG, will become the CEO and a director of the Company and Nicholas De Vito, the current CEO and controlling stockholder of the Company though the 1,000 shares of super-majority Class A Preferred Stock that he holds, will retain his positions with the Company as Treasurer, Secretary and Chief Financial Officer and director, and he will exchange his Class A Preferred shares for 2,000,000 shares of the common stock of the Company. The closing of this acquisition is contingent upon, among other things, GFG’s raising a minimum of $1,500,000 to be contributed to the Company upon closing as part of the purchased assets, for working capital purposes. There can be no assurances that GFG will be able to raise these funds or that this acquisition will successfully close.

XML 24 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCOUNTING POLICIES (Policies)
3 Months Ended
Oct. 31, 2022
Accounting Policies [Abstract]  
Consolidation

Consolidation

 

The accompanying consolidated financial statement include the accounts of the Company and its wholly owned subsidiary Duo Sciences Inc. (“DSI”)

 

Use of Estimates

Use of Estimates

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Changes in estimates are recognized in accordance with the accounting rules for the estimate, which is typically in the period when new information becomes available to management. Actual results could differ from those estimates.

 

Financial Instruments

Financial Instruments

 

Financial instruments consist of cash and accounts payable and accrued liabilities. The carrying amounts of the financial instruments approximate their fair values due to their relatively short-term nature of the underlying terms are consistent with market terms. As of the financial statement date, the Company does not hold any derivate financial instruments. Financial assets and liabilities are measured upon first recognition and reviewed at the financial statement date. Changes in fair value are recognized through profit and loss. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest or credit risks arising from these financial instruments.

 

Fair Value Measurements

Fair Value Measurements

 

The Company follows FASB Codification topic (“ASC”) 820, Fair Value Measurements and Disclosures, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.

 

The Company has adopted FASB ASC 825, Financial Instruments, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Company has not elected the fair value option for any eligible financial instruments.

 

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities, and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

 

Income Taxes

Income Taxes

 

The Company accounts for income taxes under FASB ASC Topic 740, Income Taxes (“ASC Topic 740”). Under ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As the Company has yet to produce positive cash flows from operations, no deferred tax asset or income taxes have been recorded in the financial statements.

Comprehensive Income (Loss)

Comprehensive Income (Loss)

 

The Company adopted FASB ASC 220, Reporting Comprehensive Income, which establishes standards for the reporting and display of comprehensive income and its components in the financial statements. Comprehensive income consists of net income and other gains and losses affecting stockholder’s equity that are excluded from net income, such as unrealized gains and losses on investments available for sale, foreign currency translation gains and losses and minimum pension liability. Since inception, the Company has not had any comprehensive income / loss.

 

Net Income (Loss) per Common Share

Net Income (Loss) per Common Share

 

FASB ASC 260, Earnings per share, requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations. Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per share would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Diluted net income (loss) per share on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive. Accordingly, although the diluted weighted average number of common stock outstanding is disclosed on the statements of operation, the calculated net loss per share is the same for bother basic and diluted as both are based on the basic weighted average of common stock outstanding. There were no adjustments required to net income for the period presented in the computation of diluted earnings per share.

 

Segment Reporting

Segment Reporting

 

FASB ASC 820, “Segments Reporting,” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in financial statements. The Company currently operates in one principal business segment.

 

Intangible assets

Intangible assets

 

Intangible asset are non-monetary identifiable assets, controlled by the Company that will produce future economic benefits, based on reasonable and supportable assumptions about conditions that will exist over the life of the asset. An intangible asset that does not meet these attributes will be recognized as an expense when it is incurred. Intangible assets that do, are capitalized and initially measure at cost. Those with a determinable life will be amortized on a systematic basis over their future economic life. Those with an indefinite useful life shall not be amortized until its useful life is determined to be longer than indefinite. An intangible asset subject to amortization shall be periodically reviewed for impairment. A recoverability test will be performed and, if applicable, unscheduled amortization is considered.

 

The license agreements has been capitalized, recorded at cost and amortized over its estimated useful life of ten years. Amortization has been determined based on a pro rata basis over the expected cash flows.

 

Non-cash transactions

Non-cash transactions

 

The Company follows FASB ASC 845 then recording non-cash transactions. The value of the asset received should be based on the value of the assets surrendered. However, where that value is difficult to determine, then the value could be based on the asset received, provided it is more clearly evident than the value of the asset surrendered.

Related Parties

Related Parties

 

The Company adopted FASB ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position, or cash flow.

 

The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, the more significant of which are as follows:

 

Recent Accounting Pronouncements

 

The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position, or cash flow.

XML 25 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
LICENSE PURCHASED and INTANGIBLE ASSETS (Tables)
3 Months Ended
Oct. 31, 2022
License Purchased And Intangible Assets  
Schedule of License Purchased

 

LICENSE PURCHASED and INTANGIBLE ASSETS
    October 31,     July 31,  
    2022     2022  
License   $ 125,000     $ 125,000  
Accumulated amortization     2,684       1,534  
Balance, end of year   $ 122,316     $ 123,466  
XML 26 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMPANY AND BACKGROUND (Details Narrative) - USD ($)
3 Months Ended
Apr. 15, 2021
Oct. 31, 2021
Stock Issued During Period, Value, New Issues   $ 1
Preferred Stock [Member]    
Stock Issued During Period, Value, New Issues   $ 1
Preferred Stock [Member] | Series A Preferred Stock [Member] | Nicholas De Vito [Member]    
Stock Issued During Period, Value, New Issues $ 1,000  
XML 27 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCOUNTING POLICIES (Details Narrative)
3 Months Ended
Oct. 31, 2022
Accounting Policies [Abstract]  
Finite-Lived Intangible Asset, Useful Life 10 years
XML 28 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMON and PREFERRED STOCK (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Jun. 08, 2022
Oct. 31, 2022
Jul. 31, 2022
Apr. 15, 2022
Aug. 02, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Common Stock, Shares Authorized   100,000,000 100,000,000    
Common Stock, Par or Stated Value Per Share   $ 0.0001 $ 0.0001    
Preferred Stock, Shares Authorized   10,000,000 10,000,000    
Preferred Stock, Par or Stated Value Per Share   $ 0.0001 $ 0.0001    
Stockholders' Equity, Reverse Stock Split On June 8, 2022, the Company received approval from the Financial Industry Regulatory Authority to effect a 50:1 reverse split of the Company’s outstanding common stock.        
Preferred Stock, Shares Issued   1,000 1,000    
[custom:LicenseFeeToBePaidInCommonShares]   $ 125,000 $ 125,000    
Treasury Stock, Shares   520,000 520,000 520,000  
Preferred Stock [Member] | Series A Preferred Stock [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Preferred Stock, Shares Issued         1,000
XML 29 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
LICENSE PURCHASED and INTANGIBLE ASSETS (Details) - USD ($)
3 Months Ended 12 Months Ended
Oct. 31, 2022
Jul. 31, 2022
License Purchased And Intangible Assets    
License $ 125,000 $ 125,000
Accumulated amortization 2,684 1,534
Balance, end of year $ 122,316 $ 123,466
XML 30 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
EXCLUSIVE SALES SUB-LICENSING AGREEMENT (Details Narrative)
May 11, 2022
USD ($)
Exclusive Sales Sub-licensing Agreement  
Royalty Expense $ 90,000
XML 31 pcnt-10q_htm.xml IDEA: XBRL DOCUMENT 0001504239 2022-08-01 2022-10-31 0001504239 2022-12-13 0001504239 2022-10-31 0001504239 2022-07-31 0001504239 2021-08-01 2021-10-31 0001504239 us-gaap:PreferredStockMember 2022-07-31 0001504239 us-gaap:CommonStockMember 2022-07-31 0001504239 pcnt:ShareSubscriptionReceivedMember 2022-07-31 0001504239 us-gaap:TreasuryStockMember 2022-07-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2022-07-31 0001504239 us-gaap:RetainedEarningsMember 2022-07-31 0001504239 us-gaap:PreferredStockMember 2021-07-31 0001504239 us-gaap:CommonStockMember 2021-07-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2021-07-31 0001504239 us-gaap:RetainedEarningsMember 2021-07-31 0001504239 2021-07-31 0001504239 us-gaap:PreferredStockMember 2022-08-01 2022-10-31 0001504239 us-gaap:CommonStockMember 2022-08-01 2022-10-31 0001504239 pcnt:ShareSubscriptionReceivedMember 2022-08-01 2022-10-31 0001504239 us-gaap:TreasuryStockMember 2022-08-01 2022-10-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2022-08-01 2022-10-31 0001504239 us-gaap:RetainedEarningsMember 2022-08-01 2022-10-31 0001504239 us-gaap:PreferredStockMember 2021-08-01 2021-10-31 0001504239 us-gaap:CommonStockMember 2021-08-01 2021-10-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2021-08-01 2021-10-31 0001504239 us-gaap:RetainedEarningsMember 2021-08-01 2021-10-31 0001504239 us-gaap:PreferredStockMember 2022-10-31 0001504239 us-gaap:CommonStockMember 2022-10-31 0001504239 pcnt:ShareSubscriptionReceivedMember 2022-10-31 0001504239 us-gaap:TreasuryStockMember 2022-10-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2022-10-31 0001504239 us-gaap:RetainedEarningsMember 2022-10-31 0001504239 us-gaap:PreferredStockMember 2021-10-31 0001504239 us-gaap:CommonStockMember 2021-10-31 0001504239 us-gaap:AdditionalPaidInCapitalMember 2021-10-31 0001504239 us-gaap:RetainedEarningsMember 2021-10-31 0001504239 2021-10-31 0001504239 pcnt:NicholasDeVitoMember us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-04-15 2021-04-15 0001504239 2022-06-08 2022-06-08 0001504239 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-08-02 0001504239 2022-04-15 0001504239 2021-08-01 2022-07-31 0001504239 2022-05-11 2022-05-11 iso4217:USD shares iso4217:USD shares 0001504239 false --07-31 2023 Q1 P10Y 10-Q true 2022-10-31 false 000-56356 POINT OF CARE NANO-TECHNOLOGY, INC. NV 27-2830681 109 Ambersweet Way Davenport FL 33897 (732) 723-7395 Yes Yes Non-accelerated Filer true false false 940621 5849 3198 1167 2917 7016 6115 122316 123466 129332 129581 231156 213335 231156 213335 0.0001 0.0001 10000000 10000000 1000 1000 1000 1000 1 1 0.0001 0.0001 100000000 100000000 940621 940621 940621 940621 940 940 10000 520000 520000 520 520 120191707 120191707 -120303952 -120275882 -101824 -83754 129332 129581 1150 20000 3722 3198 42254 1 28070 42255 -28070 -42255 -0.03 -0.04 940621 940621 1000 1 940621 940 -520000 -520 120191707 -120275882 -83754 10000 10000 -28070 -28070 1000 1 940621 940 10000 -520000 -520 120191707 -120303952 -101824 940621 940 120191187 -120212367 -20240 1000 1 1 -42255 -42255 1000 1 940621 940 120191187 -120254622 -62494 -28070 -42255 1150 1 17821 42254 1750 -7349 10000 10000 2651 3198 5849 <p id="xdx_80D_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zU4cTnEcwwx7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Note 1</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_826_zGQ91AUczy9d">COMPANY AND BACKGROUND</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Point of Care Nano-Technology, Inc. (the “Company”) was incorporated under the laws of the State of Nevada on June 10, 2010, under the name of “Alternative Energy and Environmental Solutions, Inc.” On August 28, 2014, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to “Unique Growing Solutions, Inc.” On March 31, 2015, the Company filed an amendment to its Articles of Incorporation changing the name of the Company to “Point of Care Nano-Technology, Inc.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On February 26, 2015, the Company’s business model was related to using its license, under a certain license agreement (the “License Agreement”) from Lamina Equities Corporation, to first develop and then manufacture saliva-based medical diagnosis products. The Company was not successful and discontinued the majority of its operations by July 31, 2016. Beginning from August 2016, the Company’s plan, which it has since discontinued, was to provide business services and financing to emerging growth entities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On April 15, 2021, the Company accepted the resignations of Dr. Guirguis and Mr. El-Salhy, received a mutual release from both, and appointed Mr. Nicholas DeVito to be Director, Chief Executive Officer and Chief Financial Officer. In addition, for his services to the Company, Mr. DeVito was awarded <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210415__20210415__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--NicholasDeVitoMember_zbuB0qAdN6n8">1,000</span> shares of Class A Preferred Stock that grants him 80% voting rights.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Also on April 15, 2021 the Company agreed to form a subsidiary and transfer all debts and the License Agreement back to Dr. Guirguis in exchange for 520,000 shares of Common Stock. On August 231, 2021, the Company formed the wholly owned subsidiary, DRG Transfer, Inc. This transaction closed on March 26, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> On July 2, 2021, the Company incorporated a wholly owned subsidiary, Duo Sciences, Inc. (“DSI”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On April 11, 2022, the Company, through DSI, acquired an exclusive license to distribute certain intellectual property in animal nutrition and animal supplements from Cedoga Consulting, LLC (“Cedoga”). On April 19, 2022, DSI signed an exclusive sales and promotion agreement with Lucy Pet Products Inc. (“Lucy”) pursuant to which Lucy will manufacture, market and distribute pet products from the Cedoga intellectual property.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company’s principal executive office location and mailing address is 109 Ambersweet Way, Davenport, FL 33897.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">These financial statements have been prepared in accordance with generally accepted principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next twelve months. Realization values may be substantially different from carrying values as shown and these financial statements do not give effect to adjustments that would be necessary to the carrying values and classifications of assets and liabilities should the Company be unable to continue as a going concern. At October 31, 2022, the Company had not yet achieved profitable operations and had accumulated losses of $120,303,952 since its inception, all of which casts substantial doubt about the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to generate future profitable operations and/or to obtain the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due.</span></p> 1000 <p id="xdx_802_ecustom--ControlByPrincipalOwnersTextBlock_zAm5tWd6EfGi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Note 2</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_820_zOIRKuDQlvy5">CONTROL BY PRINCIPAL OWNERS</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The sole director and executive officer owns, directly, beneficially and in the aggregate, the majority of the voting power of the outstanding capital stock of the Company. Accordingly, the sole director and executive officer has the ability to control the approval of most corporate actions, including approving significant expenses, increasing the authorized capital and the dissolution, merger, or sale of the Company’s assets.</span></p> <p id="xdx_808_eus-gaap--QuarterlyFinancialInformationTextBlock_zxpa0yAt7fqa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Note 3</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_821_zETOUPDn2YYa">INTERIM REPORTING</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">While the information presented in the accompanying interim three month financial statements is unaudited, it includes all adjustments, which are, in the opinion of management, necessary to present fairly the financial position, results of operations and cash flows for the interim periods presented in accordance with accounting principles generally accepted in the United States of America. These interim financial statements follow the same accounting policies and methods of their application as the Company’s July 31, 2022 annual financial statements. All adjustments are of a normal recurring nature. It is suggested that these interim financial statements be read in conjunction with the Company’s July 31, 2022 annual financial statements. Operating results for the three months ended October 31, 2022 are not necessarily indicative of the results that can be expected for the year ended July 31, 2023.</span></p> <p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zJTom7PZovQh" style="margin-top: 0; margin-bottom: 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Note 4</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_82F_zkG9XmqlVCzl">ACCOUNTING POLICIES</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, the more significant of which are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_z2AsGtMwZwEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86A_z3MparNxcw6i">Consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The accompanying consolidated financial statement include the accounts of the Company and its wholly owned subsidiary Duo Sciences Inc. (“DSI”)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zv3H9yaMIEe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86F_znDRYdEkIGmf">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Changes in estimates are recognized in accordance with the accounting rules for the estimate, which is typically in the period when new information becomes available to management. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zH8WoyYN4B27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_862_zdH7hu8tlmtk">Financial Instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Financial instruments consist of cash and accounts payable and accrued liabilities. The carrying amounts of the financial instruments approximate their fair values due to their relatively short-term nature of the underlying terms are consistent with market terms. As of the financial statement date, the Company does not hold any derivate financial instruments. Financial assets and liabilities are measured upon first recognition and reviewed at the financial statement date. Changes in fair value are recognized through profit and loss. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest or credit risks arising from these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_842_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zVURrzy5Mos6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_861_zKd9lARET7F8">Fair Value Measurements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company follows FASB Codification topic (“ASC”) 820, Fair Value Measurements and Disclosures, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company has adopted FASB ASC 825, Financial Instruments, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Company has not elected the fair value option for any eligible financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities, and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_znszs81GyUj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_863_zDaAPDpgWpYh">Income Taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company accounts for income taxes under FASB ASC Topic 740, Income Taxes (“ASC Topic 740”). Under ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As the Company has yet to produce positive cash flows from operations, no deferred tax asset or income taxes have been recorded in the financial statements.</span></p> <p id="xdx_851_z3TezO53cgqf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_849_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z4oakEFPIYek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86A_zTOnbQgr9ij7">Comprehensive Income (Loss)</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company adopted FASB ASC 220, Reporting Comprehensive Income, which establishes standards for the reporting and display of comprehensive income and its components in the financial statements. Comprehensive income consists of net income and other gains and losses affecting stockholder’s equity that are excluded from net income, such as unrealized gains and losses on investments available for sale, foreign currency translation gains and losses and minimum pension liability. Since inception, the Company has not had any comprehensive income / loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_znuGHYZIvnVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86E_zG05jYGB4205">Net Income (Loss) per Common Share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">FASB ASC 260, Earnings per share, requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations. Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per share would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Diluted net income (loss) per share on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive. Accordingly, although the diluted weighted average number of common stock outstanding is disclosed on the statements of operation, the calculated net loss per share is the same for bother basic and diluted as both are based on the basic weighted average of common stock outstanding. There were no adjustments required to net income for the period presented in the computation of diluted earnings per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_84B_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zQJDm2bzGRHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_862_zMwE4B2i5FLf">Segment Reporting</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">FASB ASC 820, “Segments Reporting,” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in financial statements. The Company currently operates in one principal business segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_84B_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zn6PjXvnhwv7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zZstJgYuQvz7">Intangible assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Intangible asset are non-monetary identifiable assets, controlled by the Company that will produce future economic benefits, based on reasonable and supportable assumptions about conditions that will exist over the life of the asset. An intangible asset that does not meet these attributes will be recognized as an expense when it is incurred. Intangible assets that do, are capitalized and initially measure at cost. Those with a determinable life will be amortized on a systematic basis over their future economic life. Those with an indefinite useful life shall not be amortized until its useful life is determined to be longer than indefinite. An intangible asset subject to amortization shall be periodically reviewed for impairment. A recoverability test will be performed and, if applicable, unscheduled amortization is considered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The license agreements has been capitalized, recorded at cost and amortized over its estimated useful life of <span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20220801__20221031_z3hR6xTFIKzi" title="::XDX::P10Y">ten years</span>. Amortization has been determined based on a pro rata basis over the expected cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_842_ecustom--NonCashTransactionsPolicyTextBlock_zDzd64HIxe39" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline">Non-cash transactions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company follows FASB ASC 845 then recording non-cash transactions. The value of the asset received should be based on the value of the assets surrendered. However, where that value is difficult to determine, then the value could be based on the asset received, provided it is more clearly evident than the value of the asset surrendered.</span></p> <p id="xdx_855_zzQqm1EVXbXf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_849_ecustom--RelatedPartiesPolicyTextBlock_z3tCGpGthAOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zuKDt7DnCxZa">Related Parties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company adopted FASB ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zYQ0aN87DcW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_862_zdyyq0SsO9hh">Recent Accounting Pronouncements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position, or cash flow.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, the more significant of which are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline">Recent Accounting Pronouncements </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position, or cash flow.</span></p> <p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_z2AsGtMwZwEl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86A_z3MparNxcw6i">Consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The accompanying consolidated financial statement include the accounts of the Company and its wholly owned subsidiary Duo Sciences Inc. (“DSI”)</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_84E_eus-gaap--UseOfEstimates_zv3H9yaMIEe4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86F_znDRYdEkIGmf">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Changes in estimates are recognized in accordance with the accounting rules for the estimate, which is typically in the period when new information becomes available to management. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_841_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zH8WoyYN4B27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_862_zdH7hu8tlmtk">Financial Instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Financial instruments consist of cash and accounts payable and accrued liabilities. The carrying amounts of the financial instruments approximate their fair values due to their relatively short-term nature of the underlying terms are consistent with market terms. As of the financial statement date, the Company does not hold any derivate financial instruments. Financial assets and liabilities are measured upon first recognition and reviewed at the financial statement date. Changes in fair value are recognized through profit and loss. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest or credit risks arising from these financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_842_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zVURrzy5Mos6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_861_zKd9lARET7F8">Fair Value Measurements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company follows FASB Codification topic (“ASC”) 820, Fair Value Measurements and Disclosures, for all financial instruments and non-financial instruments accounted for at fair value on a recurring basis. This new accounting standard establishes a single definition of fair value and a framework for measuring fair value, sets out a fair value hierarchy to be used to classify the source of information used in fair value measurement and expands disclosures about fair value measurements required under other accounting pronouncements. It does not change existing guidance as to whether or not an instrument is carried at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as inherent risk, transfer restrictions and credit risk.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company has adopted FASB ASC 825, Financial Instruments, which allows companies to choose to measure eligible financial instruments and certain other items at fair value that are not required to be measured at fair value. The Company has not elected the fair value option for any eligible financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities, and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_znszs81GyUj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_863_zDaAPDpgWpYh">Income Taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company accounts for income taxes under FASB ASC Topic 740, Income Taxes (“ASC Topic 740”). Under ASC Topic 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740-10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. As the Company has yet to produce positive cash flows from operations, no deferred tax asset or income taxes have been recorded in the financial statements.</span></p> <p id="xdx_849_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_z4oakEFPIYek" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86A_zTOnbQgr9ij7">Comprehensive Income (Loss)</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company adopted FASB ASC 220, Reporting Comprehensive Income, which establishes standards for the reporting and display of comprehensive income and its components in the financial statements. Comprehensive income consists of net income and other gains and losses affecting stockholder’s equity that are excluded from net income, such as unrealized gains and losses on investments available for sale, foreign currency translation gains and losses and minimum pension liability. Since inception, the Company has not had any comprehensive income / loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_848_eus-gaap--EarningsPerSharePolicyTextBlock_znuGHYZIvnVi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86E_zG05jYGB4205">Net Income (Loss) per Common Share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">FASB ASC 260, Earnings per share, requires dual presentation of basic and diluted earnings per share (EPS) with a reconciliation of the numerator and denominator of the EPS computations. Basic earnings per share amounts are based on the weighted average shares of common stock outstanding. If applicable, diluted earnings per share would assume the conversion, exercise or issuance of all potential common stock instruments such as options, warrants and convertible securities, unless the effect is to reduce a loss or increase earnings per share. Diluted net income (loss) per share on the potential exercise of the equity-based financial instruments is not presented where anti-dilutive. Accordingly, although the diluted weighted average number of common stock outstanding is disclosed on the statements of operation, the calculated net loss per share is the same for bother basic and diluted as both are based on the basic weighted average of common stock outstanding. There were no adjustments required to net income for the period presented in the computation of diluted earnings per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_84B_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zQJDm2bzGRHd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_862_zMwE4B2i5FLf">Segment Reporting</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">FASB ASC 820, “Segments Reporting,” establishes standards for reporting information about operating segments on a basis consistent with the Company’s internal organization structure as well as information about geographical areas, business segments and major customers in financial statements. The Company currently operates in one principal business segment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_84B_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zn6PjXvnhwv7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zZstJgYuQvz7">Intangible assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Intangible asset are non-monetary identifiable assets, controlled by the Company that will produce future economic benefits, based on reasonable and supportable assumptions about conditions that will exist over the life of the asset. An intangible asset that does not meet these attributes will be recognized as an expense when it is incurred. Intangible assets that do, are capitalized and initially measure at cost. Those with a determinable life will be amortized on a systematic basis over their future economic life. Those with an indefinite useful life shall not be amortized until its useful life is determined to be longer than indefinite. An intangible asset subject to amortization shall be periodically reviewed for impairment. A recoverability test will be performed and, if applicable, unscheduled amortization is considered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The license agreements has been capitalized, recorded at cost and amortized over its estimated useful life of <span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dxH_c20220801__20221031_z3hR6xTFIKzi" title="::XDX::P10Y">ten years</span>. Amortization has been determined based on a pro rata basis over the expected cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_842_ecustom--NonCashTransactionsPolicyTextBlock_zDzd64HIxe39" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline">Non-cash transactions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company follows FASB ASC 845 then recording non-cash transactions. The value of the asset received should be based on the value of the assets surrendered. However, where that value is difficult to determine, then the value could be based on the asset received, provided it is more clearly evident than the value of the asset surrendered.</span></p> <p id="xdx_849_ecustom--RelatedPartiesPolicyTextBlock_z3tCGpGthAOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_86C_zuKDt7DnCxZa">Related Parties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company adopted FASB ASC 850, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zYQ0aN87DcW7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline"><span id="xdx_862_zdyyq0SsO9hh">Recent Accounting Pronouncements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position, or cash flow.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America, the more significant of which are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span style="text-decoration: underline">Recent Accounting Pronouncements </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company adopts new pronouncements relating to generally accepted accounting principles applicable to the Company as they are issued, which may be in advance of their effective date. The Company does not expect the adoption of recently issued accounting pronouncements to have a significant impact on the Company’s results of operations, financial position, or cash flow.</span></p> <p id="xdx_806_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zUYSipPM5BMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Note 5</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_82C_z7UfdulRyigj">COMMON and PREFERRED STOCK</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company has authorized capital of <span id="xdx_902_eus-gaap--CommonStockSharesAuthorized_iI_c20221031_zW6a7YcygYI3">100,000,000</span> shares of common stock, par value of $<span id="xdx_905_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20221031_zS4OpOAeq138">0.0001</span> per share, and <span id="xdx_900_eus-gaap--PreferredStockSharesAuthorized_iI_c20221031_zE2qyKqwrJO3">10,000,000</span> shares of “blank check” preferred stock, par value of $<span id="xdx_904_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20221031_zxXWdeQgwFlf">0.0001</span> per share, of which 1,000 shares have been designated as Series A Nonconvertible Preferred Stock (the “Series A Preferred Stock”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">The Company had the following transactions in its common stock during the three months ended October 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On August 24, 2022, the Company completed a financing with an investor for $10,000 in exchange for Units consisting of (i) one share of common stock, par value $0.001 per share for $0.10 per share, (ii) one LOI option to purchase one share of common stock for $0.20 per share upon the Company signing a letter of intent with a third party and (iii) one Agreement option to purchase one share of common stock for $0.30 per share upon the Company signing an agreement with a third party. The shares have not yet been issued and transactions has been recorded as subscriptions received.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">During the year ended July 31, 2022, the Company had the following transactions in its common and preferred stock:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><span id="xdx_902_eus-gaap--StockholdersEquityReverseStockSplit_c20220608__20220608_zfW3riS7tSjf">On June 8, 2022, the Company received approval from the Financial Industry Regulatory Authority to effect a 50:1 reverse split of the Company’s outstanding common stock.</span> The split was reflected in the public markets on June 9, 2022 and has been given retroactive disclosure in the financial statements. Accordingly, all references to common shares in these financial statements reflect the reverse split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On August 2, 2021, the Company issued <span id="xdx_906_eus-gaap--PreferredStockSharesIssued_iI_c20210802__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zS6NKqewtmJc">1,000</span> Series A Preferred Stock to Nicholas DeVito, the Company’s Chief Executive Officer as compensation. The Preferred Stock gives DeVito 80% control of the voting stock of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On April 10, 2022, the Company entered into an agreement under which it agreed to issue 300,000 common shares in order to obtain a license to distribute product (See below). The Company has not yet issued those shares and the obligation to do so is included in the accounts as a $<span id="xdx_909_ecustom--LicenseFeeToBePaidInCommonShares_c20220801__20221031_zjiEa1luW6G1">125,000</span> liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On April 15, 2022, as part of the Settlement agreement (See below), the Company received into treasury <span id="xdx_907_eus-gaap--TreasuryStockShares_iI_c20220415_zVxGsRb1PXVi">520,000</span> shares of common stock (26,000,000 pre reverse split shares).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">There were no warrants or options outstanding as of October 31, 2022.</span></p> 100000000 0.0001 10000000 0.0001 On June 8, 2022, the Company received approval from the Financial Industry Regulatory Authority to effect a 50:1 reverse split of the Company’s outstanding common stock. 1000 125000 520000 <p id="xdx_80E_ecustom--SettlementContractsDisclosureTextBlock_zdiK2rY7o0r6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Note 6</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_82C_z5qfUdimkHYa">SETTLEMENT AGREEMENT</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On April 15, 2021, the Company formed a wholly owned subsidiary, DRG Transfer Inc. (“DRG”) and transferred all Company debts relating to the License Agreement business and the License Agreement to DRG to be split off to Dr. Guirguis in exchange for 520,000 share (26,000,000 shares pre reverse split) of the Company’s common stock held by Dr. Guirguis. This transaction closed on March 26, 2022 with Dr. Guirguis giving up and transferring to DRG all the rights, title and interest in the 520,000 shares and DRG contributing all of the legacy business debt and the License Agreement to DRG Transfer, Inc, a Nevada corporation, and transferring all of the outstanding capital stock in DRG Transfer, Inc. to Dr. Guirguis.</span></p> <p id="xdx_80B_ecustom--LicensePurchasedTextBlock_zkUWb2SIoiT2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Note 7</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_822_z16upC2B2ey8">LICENSE PURCHASED and INTANGIBLE ASSETS</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On April 11, 2022, the Company, through its wholly owned subsidiary DSI, acquired an exclusive license to distribute in the USA, Canada and Mexico, certain intellectual property in animal nutrition and animal supplements from Cedoga Consulting, LLC. The Company receives 10% of all licensing fees due to Cedoga in exchange for 300,000 post reverse split shares of common stock of the Company. Under the terms of the agreement, the Company will pay royalties from sub-licensing on the following basis:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">90% of net royalties for sale and initial payments up to $100,000,000 per calendar year.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">95% of net royalties received for continuing sales above $100,000,000 per calendar year.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">90% of any lump up-front payment sub-licensing fees.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Option to purchase 200,000 shares of the Company’s common stock when net sales exceed $100,000,000.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> The license value has been based on the expected discounted cash flows the license will generate to the Company over its estimated 10 year life. The Company’s common shares are very lightly traded and management determined that their market value are not reliable as a determinant of value for this transaction.</span></p> <p style="margin: 0"> </p> <p id="xdx_89F_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zcQx6sN0iqJi" style="margin: 0"><span id="xdx_8B4_zZvx3n0iEpdl" style="display: none">Schedule of License Purchased</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--DisclosureLicensePurchasedAndIntangibleAssetsDetailsAbstract_zirfJ7tt7mv5" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse" summary="xdx: Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" id="xdx_49D_20220801__20221031_z1TterAUbwjf" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">October 31,</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" id="xdx_492_20210801__20220731_zk1GOCtIBQ4l" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">July 31,</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_401_ecustom--LicenseFeeToBePaidInCommonShares_zdRKozO7Fuc6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">License</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">125,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 18.8pt; text-align: right; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">125,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_z6sh0vUyE2J7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Accumulated amortization</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2,684</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 18.8pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">1,534</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_40B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iE_znffSYvduXL1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Balance, end of year</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">122,316</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; padding-left: 18.8pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">123,466</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td></tr> </table> <p id="xdx_8A0_zPWEOVs48gE" style="margin-top: 0; margin-bottom: 0"/> <p id="xdx_89F_eus-gaap--ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_zcQx6sN0iqJi" style="margin: 0"><span id="xdx_8B4_zZvx3n0iEpdl" style="display: none">Schedule of License Purchased</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_88B_ecustom--DisclosureLicensePurchasedAndIntangibleAssetsDetailsAbstract_zirfJ7tt7mv5" style="font: 10pt Times New Roman, Times, Serif; width: 90%; border-collapse: collapse" summary="xdx: Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS (Details)"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" id="xdx_49D_20220801__20221031_z1TterAUbwjf" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">October 31,</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" id="xdx_492_20210801__20220731_zk1GOCtIBQ4l" style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">July 31,</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2022</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_401_ecustom--LicenseFeeToBePaidInCommonShares_zdRKozO7Fuc6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 64%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">License</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">125,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 18.8pt; text-align: right; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">125,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease_z6sh0vUyE2J7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Accumulated amortization</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">2,684</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-left: 18.8pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">1,534</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td></tr> <tr id="xdx_40B_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iE_znffSYvduXL1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Balance, end of year</span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">122,316</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; padding-left: 18.8pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">123,466</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td></tr> </table> 125000 125000 2684 1534 122316 123466 <p id="xdx_80B_ecustom--ExclusiveSalesSubLicensingAgreementTextBlock_ztGr26bAtjvh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Note 8</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_823_zybu6yb2BNfe">EXCLUSIVE SALES  SUB-LICENSING AGREEMENT</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On April 19, 2022, DSI signed an exclusive sales and promotion sub-licensing agreement with Lucy Pet Products Inc. (“Lucy”) pursuant to which Lucy will manufacture, market and distribute pet products derived from the Cedoga intellectual property. The terms of the sub-licensing agreement are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Lucy will pay the Company a one-time sub-license fee of $100,000 on execution of the sub-licensing agreement.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">Lucy will pay the Company royalties of 5% of Net Revenue, calculated and payable quarterly. Net Revenue is defined as total revenue less direct cost of materials, manufacturing, packaging and delivery expenses and less excise, sales or similar taxes.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On May 11, 2022, the Company received the first payment from Lucy of $100,000 under its sub-license agreement with Lucy and remitted $<span id="xdx_907_eus-gaap--RoyaltyExpense_c20220511__20220511_zrBUI2yMT8S6">90,000</span> to Cedoga according to the Cedoga license agreement.</span></p> 90000 <p id="xdx_80F_eus-gaap--SubsequentEventsTextBlock_zBpnj7YIRiDd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b>Note 9</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"><b><span id="xdx_827_zD4CrhQSpYwh">SUBSEQUENT EVENTS</span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On August 24, 2022, the Company completed a financing with an investor for $10,000 in exchange for Units consisting of (i) one share of common stock, par value $0.001 per share for $0.10 per share, (ii) one LOI option to purchase one share of common stock for $0.20 per share upon the Company signing a letter of intent with a third party and (iii) one Agreement option to purchase one share of common stock for $0.30 per share upon the Company signing an agreement with a third party.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black">On November 12, 2022 the investor exercised their right to purchase $10,000 of common stock for $0.20 per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 12, 2022, the Company entered into an asset purchase agreement with Global Foods Group, LLC (“GFG”) and its principal shareholder pursuant to which it agreed to acquire substantially all of the assets of GFG, consisting of assets relating to the sugar substitute that GFG has been developing, Jaca<sup>®</sup>. In exchange for the Jaca related assets, the Company will issue to GFG and its designees 7,000,000 shares of the Company’s common stock. Upon the closing of this transaction, which will effect a change of control of the Company, Peter Ferrari, the principal of the controlling member of GFG, will become the CEO and a director of the Company and Nicholas De Vito, the current CEO and controlling stockholder of the Company though the 1,000 shares of super-majority Class A Preferred Stock that he holds, will retain his positions with the Company as Treasurer, Secretary and Chief Financial Officer and director, and he will exchange his Class A Preferred shares for 2,000,000 shares of the common stock of the Company. The closing of this acquisition is contingent upon, among other things, GFG’s raising a minimum of $1,500,000 to be contributed to the Company upon closing as part of the purchased assets, for working capital purposes. There can be no assurances that GFG will be able to raise these funds or that this acquisition will successfully close.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Black"/></p> EXCEL 32 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 33 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 34 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 35 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 43 97 1 false 8 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://pcnt/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - INTERIM BALANCE SHEETS (Unaudited) Sheet http://pcnt/role/InterimBalanceSheets INTERIM BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - INTERIM BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://pcnt/role/InterimBalanceSheetsParenthetical INTERIM BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - INTERIM STATEMENTS OF OPERATIONS (Unaudited) Sheet http://pcnt/role/InterimStatementsOfOperations INTERIM STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - INTERIM STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) Sheet http://pcnt/role/InterimStatementsOfStockholdersEquity INTERIM STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - INTERIM STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://pcnt/role/InterimStatementsOfCashFlows INTERIM STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - COMPANY AND BACKGROUND Sheet http://pcnt/role/CompanyAndBackground COMPANY AND BACKGROUND Notes 7 false false R8.htm 00000008 - Disclosure - CONTROL BY PRINCIPAL OWNERS Sheet http://pcnt/role/ControlByPrincipalOwners CONTROL BY PRINCIPAL OWNERS Notes 8 false false R9.htm 00000009 - Disclosure - INTERIM REPORTING Sheet http://pcnt/role/InterimReporting INTERIM REPORTING Notes 9 false false R10.htm 00000010 - Disclosure - ACCOUNTING POLICIES Sheet http://pcnt/role/AccountingPolicies ACCOUNTING POLICIES Notes 10 false false R11.htm 00000011 - Disclosure - COMMON and PREFERRED STOCK Sheet http://pcnt/role/CommonAndPreferredStock COMMON and PREFERRED STOCK Notes 11 false false R12.htm 00000012 - Disclosure - SETTLEMENT AGREEMENT Sheet http://pcnt/role/SettlementAgreement SETTLEMENT AGREEMENT Notes 12 false false R13.htm 00000013 - Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS Sheet http://pcnt/role/LicensePurchasedAndIntangibleAssets LICENSE PURCHASED and INTANGIBLE ASSETS Notes 13 false false R14.htm 00000014 - Disclosure - EXCLUSIVE SALES SUB-LICENSING AGREEMENT Sheet http://pcnt/role/ExclusiveSalesSub-licensingAgreement EXCLUSIVE SALES SUB-LICENSING AGREEMENT Notes 14 false false R15.htm 00000015 - Disclosure - SUBSEQUENT EVENTS Sheet http://pcnt/role/SubsequentEvents SUBSEQUENT EVENTS Notes 15 false false R16.htm 00000016 - Disclosure - ACCOUNTING POLICIES (Policies) Sheet http://pcnt/role/AccountingPoliciesPolicies ACCOUNTING POLICIES (Policies) Policies 16 false false R17.htm 00000017 - Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS (Tables) Sheet http://pcnt/role/LicensePurchasedAndIntangibleAssetsTables LICENSE PURCHASED and INTANGIBLE ASSETS (Tables) Tables http://pcnt/role/LicensePurchasedAndIntangibleAssets 17 false false R18.htm 00000018 - Disclosure - COMPANY AND BACKGROUND (Details Narrative) Sheet http://pcnt/role/CompanyAndBackgroundDetailsNarrative COMPANY AND BACKGROUND (Details Narrative) Details http://pcnt/role/CompanyAndBackground 18 false false R19.htm 00000019 - Disclosure - ACCOUNTING POLICIES (Details Narrative) Sheet http://pcnt/role/AccountingPoliciesDetailsNarrative ACCOUNTING POLICIES (Details Narrative) Details http://pcnt/role/AccountingPoliciesPolicies 19 false false R20.htm 00000020 - Disclosure - COMMON and PREFERRED STOCK (Details Narrative) Sheet http://pcnt/role/CommonAndPreferredStockDetailsNarrative COMMON and PREFERRED STOCK (Details Narrative) Details http://pcnt/role/CommonAndPreferredStock 20 false false R21.htm 00000021 - Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS (Details) Sheet http://pcnt/role/LicensePurchasedAndIntangibleAssetsDetails LICENSE PURCHASED and INTANGIBLE ASSETS (Details) Details http://pcnt/role/LicensePurchasedAndIntangibleAssetsTables 21 false false R22.htm 00000022 - Disclosure - EXCLUSIVE SALES SUB-LICENSING AGREEMENT (Details Narrative) Sheet http://pcnt/role/ExclusiveSalesSub-licensingAgreementDetailsNarrative EXCLUSIVE SALES SUB-LICENSING AGREEMENT (Details Narrative) Details http://pcnt/role/ExclusiveSalesSub-licensingAgreement 22 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:FiniteLivedIntangibleAssetUsefulLife - pcnt-10q.htm 52 pcnt-10q.htm pcnt-20221031.xsd pcnt-20221031_cal.xml pcnt-20221031_def.xml pcnt-20221031_lab.xml pcnt-20221031_pre.xml pcnt-ex31.htm pcnt-ex32.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 38 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "pcnt-10q.htm": { "axisCustom": 0, "axisStandard": 3, "contextCount": 43, "dts": { "calculationLink": { "local": [ "pcnt-20221031_cal.xml" ] }, "definitionLink": { "local": [ "pcnt-20221031_def.xml" ] }, "inline": { "local": [ "pcnt-10q.htm" ] }, "labelLink": { "local": [ "pcnt-20221031_lab.xml" ] }, "presentationLink": { "local": [ "pcnt-20221031_pre.xml" ] }, "schema": { "local": [ "pcnt-20221031.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 170, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 18, "http://pcnt/20221031": 8, "http://xbrl.sec.gov/dei/2022": 5, "total": 31 }, "keyCustom": 13, "keyStandard": 84, "memberCustom": 2, "memberStandard": 6, "nsprefix": "pcnt", "nsuri": "http://pcnt/20221031", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://pcnt/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - ACCOUNTING POLICIES", "role": "http://pcnt/role/AccountingPolicies", "shortName": "ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - COMMON and PREFERRED STOCK", "role": "http://pcnt/role/CommonAndPreferredStock", "shortName": "COMMON and PREFERRED STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "pcnt:SettlementContractsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - SETTLEMENT AGREEMENT", "role": "http://pcnt/role/SettlementAgreement", "shortName": "SETTLEMENT AGREEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "pcnt:SettlementContractsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "pcnt:LicensePurchasedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS", "role": "http://pcnt/role/LicensePurchasedAndIntangibleAssets", "shortName": "LICENSE PURCHASED and INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "pcnt:LicensePurchasedTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "pcnt:ExclusiveSalesSubLicensingAgreementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - EXCLUSIVE SALES SUB-LICENSING AGREEMENT", "role": "http://pcnt/role/ExclusiveSalesSub-licensingAgreement", "shortName": "EXCLUSIVE SALES SUB-LICENSING AGREEMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "pcnt:ExclusiveSalesSubLicensingAgreementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - SUBSEQUENT EVENTS", "role": "http://pcnt/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - ACCOUNTING POLICIES (Policies)", "role": "http://pcnt/role/AccountingPoliciesPolicies", "shortName": "ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConsolidationPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "pcnt:LicensePurchasedTextBlock", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS (Tables)", "role": "http://pcnt/role/LicensePurchasedAndIntangibleAssetsTables", "shortName": "LICENSE PURCHASED and INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "pcnt:LicensePurchasedTextBlock", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2021-08-012021-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - COMPANY AND BACKGROUND (Details Narrative)", "role": "http://pcnt/role/CompanyAndBackgroundDetailsNarrative", "shortName": "COMPANY AND BACKGROUND (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2021-04-152021-04-15_us-gaap_PreferredStockMember_us-gaap_SeriesAPreferredStockMember_custom_NicholasDeVitoMember", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R19": { "firstAnchor": null, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - ACCOUNTING POLICIES (Details Narrative)", "role": "http://pcnt/role/AccountingPoliciesDetailsNarrative", "shortName": "ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "AsOf2022-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - INTERIM BALANCE SHEETS (Unaudited)", "role": "http://pcnt/role/InterimBalanceSheets", "shortName": "INTERIM BALANCE SHEETS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "AsOf2022-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "AsOf2022-10-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - COMMON and PREFERRED STOCK (Details Narrative)", "role": "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "shortName": "COMMON and PREFERRED STOCK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-06-082022-06-08", "decimals": null, "lang": "en-US", "name": "us-gaap:StockholdersEquityReverseStockSplit", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": "0", "first": true, "lang": null, "name": "pcnt:LicenseFeeToBePaidInCommonShares", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - LICENSE PURCHASED and INTANGIBLE ASSETS (Details)", "role": "http://pcnt/role/LicensePurchasedAndIntangibleAssetsDetails", "shortName": "LICENSE PURCHASED and INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "pcnt:DisclosureLicensePurchasedAndIntangibleAssetsDetailsAbstract", "pcnt:LicensePurchasedTextBlock", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": "0", "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "span", "p", "pcnt:ExclusiveSalesSubLicensingAgreementTextBlock", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-05-112022-05-11", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RoyaltyExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - EXCLUSIVE SALES SUB-LICENSING AGREEMENT (Details Narrative)", "role": "http://pcnt/role/ExclusiveSalesSub-licensingAgreementDetailsNarrative", "shortName": "EXCLUSIVE SALES SUB-LICENSING AGREEMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "pcnt:ExclusiveSalesSubLicensingAgreementTextBlock", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-05-112022-05-11", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RoyaltyExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "AsOf2022-10-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - INTERIM BALANCE SHEETS (Unaudited) (Parenthetical)", "role": "http://pcnt/role/InterimBalanceSheetsParenthetical", "shortName": "INTERIM BALANCE SHEETS (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesOutstanding", "us-gaap:PreferredStockSharesIssued", "us-gaap:PreferredStockSharesIssued", "span", "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "AsOf2022-10-31", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DepreciationAndAmortization", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - INTERIM STATEMENTS OF OPERATIONS (Unaudited)", "role": "http://pcnt/role/InterimStatementsOfOperations", "shortName": "INTERIM STATEMENTS OF OPERATIONS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": "0", "lang": null, "name": "pcnt:ConsultingExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "AsOf2021-07-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - INTERIM STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)", "role": "http://pcnt/role/InterimStatementsOfStockholdersEquity", "shortName": "INTERIM STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "AsOf2021-07-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - INTERIM STATEMENTS OF CASH FLOWS (Unaudited)", "role": "http://pcnt/role/InterimStatementsOfCashFlows", "shortName": "INTERIM STATEMENTS OF CASH FLOWS (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInAccountsPayable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - COMPANY AND BACKGROUND", "role": "http://pcnt/role/CompanyAndBackground", "shortName": "COMPANY AND BACKGROUND", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "pcnt:ControlByPrincipalOwnersTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - CONTROL BY PRINCIPAL OWNERS", "role": "http://pcnt/role/ControlByPrincipalOwners", "shortName": "CONTROL BY PRINCIPAL OWNERS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "pcnt:ControlByPrincipalOwnersTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - INTERIM REPORTING", "role": "http://pcnt/role/InterimReporting", "shortName": "INTERIM REPORTING", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "pcnt-10q.htm", "contextRef": "From2022-08-01to2022-10-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 8, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r215", "r217", "r218" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r207" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r210" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r212" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r205" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r209" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r208" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://pcnt/role/Cover" ], "xbrltype": "booleanItemType" }, "pcnt_ConsultingExpense": { "auth_ref": [], "calculation": { "http://pcnt/role/InterimStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Consulting Expense" } } }, "localname": "ConsultingExpense", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/InterimStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "pcnt_ControlByPrincipalOwnersTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONTROL BY PRINCIPAL OWNERS" } } }, "localname": "ControlByPrincipalOwnersTextBlock", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/ControlByPrincipalOwners" ], "xbrltype": "textBlockItemType" }, "pcnt_DisclosureControlByPrincipalOwnersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Control By Principal Owners" } } }, "localname": "DisclosureControlByPrincipalOwnersAbstract", "nsuri": "http://pcnt/20221031", "xbrltype": "stringItemType" }, "pcnt_DisclosureExclusiveSalesSublicensingAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Exclusive Sales Sub-licensing Agreement" } } }, "localname": "DisclosureExclusiveSalesSublicensingAgreementAbstract", "nsuri": "http://pcnt/20221031", "xbrltype": "stringItemType" }, "pcnt_DisclosureLicensePurchasedAndIntangibleAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "License Purchased And Intangible Assets" } } }, "localname": "DisclosureLicensePurchasedAndIntangibleAssetsAbstract", "nsuri": "http://pcnt/20221031", "xbrltype": "stringItemType" }, "pcnt_DisclosureLicensePurchasedAndIntangibleAssetsDetailsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "DisclosureLicensePurchasedAndIntangibleAssetsDetailsAbstract", "verboseLabel": "LICENSE PURCHASED and INTANGIBLE ASSETS" } } }, "localname": "DisclosureLicensePurchasedAndIntangibleAssetsDetailsAbstract", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/LicensePurchasedAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "pcnt_DisclosureSettlementAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Settlement Agreement" } } }, "localname": "DisclosureSettlementAgreementAbstract", "nsuri": "http://pcnt/20221031", "xbrltype": "stringItemType" }, "pcnt_EarningsPerShareBasicAndDiluted1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Net Loss per share, basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted1", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/InterimStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "pcnt_ExclusiveSalesSubLicensingAgreementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "EXCLUSIVE SALES SUB-LICENSING AGREEMENT" } } }, "localname": "ExclusiveSalesSubLicensingAgreementTextBlock", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/ExclusiveSalesSub-licensingAgreement" ], "xbrltype": "textBlockItemType" }, "pcnt_LicenseFeeToBePaidInCommonShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "[custom:LicenseFeeToBePaidInCommonShares]", "verboseLabel": "License" } } }, "localname": "LicenseFeeToBePaidInCommonShares", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/LicensePurchasedAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "pcnt_LicensePurchasedTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LICENSE PURCHASED and INTANGIBLE ASSETS" } } }, "localname": "LicensePurchasedTextBlock", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/LicensePurchasedAndIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "pcnt_NicholasDeVitoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nicholas De Vito [Member]" } } }, "localname": "NicholasDeVitoMember", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/CompanyAndBackgroundDetailsNarrative" ], "xbrltype": "domainItemType" }, "pcnt_NonCashTransactionsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non-cash transactions" } } }, "localname": "NonCashTransactionsPolicyTextBlock", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "pcnt_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "pcnt_SettlementContractsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SETTLEMENT AGREEMENT" } } }, "localname": "SettlementContractsDisclosureTextBlock", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/SettlementAgreement" ], "xbrltype": "textBlockItemType" }, "pcnt_ShareSubscriptionReceived": { "auth_ref": [], "calculation": { "http://pcnt/role/InterimStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "ShareSubscriptionReceived", "verboseLabel": "Share subscriptions received" } } }, "localname": "ShareSubscriptionReceived", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows", "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "pcnt_ShareSubscriptionReceivedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Subscription Received [Member]" } } }, "localname": "ShareSubscriptionReceivedMember", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "pcnt_ShareSubscriptionsReceived": { "auth_ref": [], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Share subscriptions received" } } }, "localname": "ShareSubscriptionsReceived", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "pcnt_WeightedAverageNumberOfShareOutstandingBasicAndDiluted1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted average number of common shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted1", "nsuri": "http://pcnt/20221031", "presentation": [ "http://pcnt/role/InterimStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r18", "r170" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable and Accrued Expenses" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease": { "auth_ref": [ "r103" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accumulated depreciation, depletion and amortization of property, plant and equipment.", "label": "Accumulated amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/LicensePurchasedAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r25", "r26", "r158", "r159", "r160", "r161", "r162", "r163" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r11", "r170" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r45", "r46", "r47", "r135", "r136", "r137", "r152" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Cash Expense:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r7", "r43", "r79", "r87", "r91", "r95", "r104", "r105", "r106", "r107", "r108", "r109", "r110", "r111", "r112", "r113", "r114", "r146", "r149", "r156", "r168", "r170", "r190", "r193" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r17", "r43", "r95", "r104", "r105", "r106", "r107", "r108", "r109", "r110", "r111", "r112", "r113", "r114", "r146", "r149", "r156", "r168", "r170" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r2", "r44", "r78" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "COMPANY AND BACKGROUND" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CompanyAndBackground" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r6", "r37" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Ending Cash", "periodStartLabel": "Beginning Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r32", "r157" ], "calculation": { "http://pcnt/role/InterimStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Change in cash for the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r6" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r8", "r9", "r10", "r41", "r43", "r57", "r58", "r59", "r61", "r62", "r68", "r69", "r70", "r95", "r104", "r108", "r109", "r110", "r113", "r114", "r115", "r116", "r118", "r122", "r128", "r156", "r220" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/CompanyAndBackgroundDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r45", "r46", "r152" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par Value", "verboseLabel": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r10", "r128" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r10", "r170" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, par value $.0001; 100,000,000 shares authorized; 940,621 shares issued and outstanding (Note 5)" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income (Loss)" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r39", "r148" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r35", "r103" ], "calculation": { "http://pcnt/role/InterimStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Amortization Expense", "verboseLabel": "Amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows", "http://pcnt/role/InterimStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r63", "r64" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Income (Loss) per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r25", "r26", "r27", "r45", "r46", "r47", "r49", "r54", "r56", "r67", "r96", "r128", "r129", "r135", "r136", "r137", "r144", "r145", "r152", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r197", "r198", "r199" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/CompanyAndBackgroundDetailsNarrative", "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r154", "r155" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Asset, Useful Life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r31" ], "calculation": { "http://pcnt/role/InterimStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r24", "r138", "r139", "r140", "r141", "r142", "r143" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r34" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Accounts payable and Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in Working Capital Items:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r34" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Prepaid expense" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r40", "r102", "r173", "r174", "r175", "r177" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r100", "r101" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Asset - License (Note 7)", "periodEndLabel": "Balance, end of year" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets", "http://pcnt/role/LicensePurchasedAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r19", "r43", "r88", "r95", "r104", "r105", "r106", "r108", "r109", "r110", "r111", "r112", "r113", "r114", "r147", "r149", "r150", "r156", "r168", "r169" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r15", "r43", "r95", "r156", "r170", "r191", "r195" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Stockholders\u0092 Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u0092 DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r32" ], "calculation": { "http://pcnt/role/InterimStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r32", "r33", "r36" ], "calculation": { "http://pcnt/role/InterimStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r22", "r23", "r27", "r28", "r36", "r43", "r48", "r50", "r51", "r52", "r53", "r55", "r56", "r60", "r79", "r86", "r89", "r90", "r92", "r95", "r104", "r105", "r106", "r108", "r109", "r110", "r111", "r112", "r113", "r114", "r153", "r156", "r192", "r196" ], "calculation": { "http://pcnt/role/InterimStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Loss", "totalLabel": "Net Loss and Comprehensive Loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows", "http://pcnt/role/InterimStatementsOfOperations", "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OfficersCompensation": { "auth_ref": [ "r29" ], "calculation": { "http://pcnt/role/InterimStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold.", "label": "Officer compensation", "verboseLabel": "Officer Compensation" } } }, "localname": "OfficersCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfCashFlows", "http://pcnt/role/InterimStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://pcnt/role/InterimStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses [Default Label]", "totalLabel": "Operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/CompanyAndBackgroundDetailsNarrative", "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r9", "r115" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par Value", "verboseLabel": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r9", "r115" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r9" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r9", "r170" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, par value $.0001; 10,000,000 shares authorized; 1,000 shares issued and outstanding (Note 5)" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r16", "r97", "r98" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r202", "r203" ], "calculation": { "http://pcnt/role/InterimStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Professional Fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Quarterly Financial Information Disclosure [Abstract]" } } }, "localname": "QuarterlyFinancialInformationDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "auth_ref": [ "r65", "r66" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.", "label": "INTERIM REPORTING" } } }, "localname": "QuarterlyFinancialInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimReporting" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r134", "r165", "r166" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CompanyAndBackgroundDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r134", "r165", "r167", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r188", "r189" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CompanyAndBackgroundDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r12", "r129", "r170", "r194", "r200", "r201" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r45", "r46", "r47", "r49", "r54", "r56", "r96", "r135", "r136", "r137", "r144", "r145", "r152", "r197", "r199" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RoyaltyExpense": { "auth_ref": [ "r30" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.", "label": "Royalty Expense" } } }, "localname": "RoyaltyExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/ExclusiveSalesSub-licensingAgreementDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r99" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of License Purchased" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/LicensePurchasedAndIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r80", "r81", "r82", "r83", "r84", "r85", "r93" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r8", "r9", "r128" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/CompanyAndBackgroundDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending Balance, Shares", "periodStartLabel": "Beginning Balance, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r38", "r44" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r8", "r9", "r10", "r41", "r43", "r57", "r58", "r59", "r61", "r62", "r68", "r69", "r70", "r95", "r104", "r108", "r109", "r110", "r113", "r114", "r115", "r116", "r118", "r122", "r128", "r156", "r220" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/CompanyAndBackgroundDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r21", "r25", "r26", "r27", "r45", "r46", "r47", "r49", "r54", "r56", "r67", "r96", "r128", "r129", "r135", "r136", "r137", "r144", "r145", "r152", "r158", "r159", "r160", "r161", "r162", "r163", "r164", "r197", "r198", "r199" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/CompanyAndBackgroundDetailsNarrative", "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CompanyAndBackgroundDetailsNarrative", "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r45", "r46", "r47", "r67", "r176" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CompanyAndBackgroundDetailsNarrative", "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r9", "r10", "r128", "r129" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Shares Issued, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r9", "r10", "r128", "r129" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Shares issued", "verboseLabel": "Stock Issued During Period, Value, New Issues" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CompanyAndBackgroundDetailsNarrative", "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r10", "r13", "r14", "r43", "r94", "r95", "r156", "r170" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "Total Stockholders\u0092 Deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets", "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u0092 Deficit" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r42", "r116", "r117", "r118", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r129", "r133", "r151" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "COMMON and PREFERRED STOCK" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Stockholders' Equity, Reverse Stock Split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r171", "r172" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r20", "r131" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r20", "r131" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/CommonAndPreferredStockDetailsNarrative", "http://pcnt/role/InterimBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r20", "r131", "r132" ], "calculation": { "http://pcnt/role/InterimBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury Stock - 520,000 shares" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/InterimBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r71", "r72", "r73", "r74", "r75", "r76", "r77" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://pcnt/role/AccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r133": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r172": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r204": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r205": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r206": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r207": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r208": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r209": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r211": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r212": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r213": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r214": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r215": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r216": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r217": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r218": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r219": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r220": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r221": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r222": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r223": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r224": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r44": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL124452896-108306" }, "r66": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "270", "URI": "https://asc.fasb.org/topic&trid=2126967" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r78": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" } }, "version": "2.1" } ZIP 39 0001199835-22-000769-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001199835-22-000769-xbrl.zip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end